US Pat. No. 9,315,784

MODIFIED TRANSKETOLASE AND USE THEREOF

DSM IP ASSETS B.V., Heer...

1. A modified transketolase originated from Bacillus or Corynebacterium, wherein the amino acid sequence of the modified transketolase contains at least one mutation, so that the specific activity
of the modified enzyme is reduced in comparison to the corresponding non-modified wild-type enzyme, said at least one mutation
leading to a reduced activity of between 10 to 90% towards metabolism of carbon sources that are exclusively metabolized by
the pentose phosphate pathway compared to the activity of the respective non-modified wild-type enzyme.
US Pat. No. 9,518,252

LISTERIA BACTERIOPHAGE P825 AND USES THEREOF

DSM IP ASSETS B.V., Heer...

1. A food product comprising a bacteriophage having a genome
i) comprising the DNA sequence of SEQ ID NO: 7;
ii) having at least 90% or 95% sequence identity with the DNA sequence of SEQ ID NO: 7; or
iii) having at least 90% or 95% sequence identity with the DNA sequence of the genome of bacteriophage ProCC P825 deposited
under Accession No. DSM 23783;

wherein the food product is selected from the group consisting of a dairy product, a fruit product, a vegetable product, a
meat product, and a fish product.

US Pat. No. 9,149,048

PURIFIED LACTASE

DSM IP ASSETS B.V., Heer...

1. A lactase solution comprising Kluyveromyces lactase and a stabilizing solvent,
wherein the solution comprises less than 10 g/kg of poly and oligosaccharides, and
wherein the stabilizing solvent is sorbitol or glycerol.
US Pat. No. 9,149,430

COMPOSITIONS COMPRISING CAROTENOIDS

DSM IP ASSETS B.V., Heer...

1. An edible composition consisting of:
at least 25% by weight (based on the dry weight of the total composition) of a pectin, excluding beet pectin, wherein the
pectin has a degree of esterification (DE) below 50% and gelatinizes by ionotropic gel formation, and, encapsulated in the
pectin is

at least 0.2% by weight (based on the dry weight of the total composition) of a carotenoid selected from the group consisting
of ?-carotene, ?-carotene, lycopene, astaxanthin, canthaxanthin, lutein, zeaxanthin, and mixtures thereof as an active ingredient,
and

0.01-5% by weight (based on the dry weight of the total composition) of an antioxidant,
wherein most of the carotenoid encapsulated in the pectin remains intact and passes the stomach and intestine.

US Pat. No. 9,221,973

RESIN COMPOSITION

DSM IP ASSETS B.V., Heer...

1. A resin composition comprising:
(a) 30 to 80 wt. % of an unsaturated polyester resin and/or a vinyl ester resin,
(b) 10 to 50 wt. % of styrene as reactive diluent,
(c) dimethylitaconate as reactive diluent,

wherein the dimethylitaconate is present in an amount of 1 to 80 wt. %, based on total amount of reactive diluent present
in the resin composition, and

(d) 1 to 5 wt. % of a paraffin oil and/or a paraffin wax, based on total amount of the unsaturated polyester resin and vinyl
ester resin, reactive diluent and paraffin oil and/or paraffin wax present in the resin composition.

US Pat. No. 9,249,247

ACRYLIC POLYMER

DSM IP ASSETS B.V., Heer...

1. A cosmetic composition comprising:
(a) an acrylic emulsion polymer which is an emulsion polymerized reaction product of a monomer mixture of raw monomer materials
consisting of methacrylic acid, n-butyl methacrylate, ethyl acrylate, ethyl methacrylate, and less than 5 wt. %, based on
100 wt. % of the monomer mixture, of impurities or additives which may be present in the raw monomer materials, and

(b) a cosmetically acceptable carrier.
US Pat. No. 9,163,223

POLYPEPTIDE HAVING ACETYL XYLAN ESTERASE ACTIVITY AND USES THEREOF

DSM IP ASSETS B.V., Heer...

1. A variant polypeptide having at least 97% sequence identity with the sequence set out in SEQ ID NO: 2 or the mature form
thereof, wherein said variant polypeptide or mature form thereof has one or more substitutions or insertions relative to SEQ
ID NO:2 and wherein said variant polypeptide has acetyl xylan esterase activity.
US Pat. No. 9,295,190

SEED TREATMENT COMPOSITION

DSM IP ASSETS B.V., Heer...

1. A method for improving seed germination, said method comprising coating the seed with a composition comprising an effective
amount of natamycin and a filler, a binder or both to produce a coated seed, wherein the effective amount of natamycin improves
germination of the coated seed at least 5% as measured by percent of germination after 14 days.
US Pat. No. 9,249,434

PRODUCTION OF HIGH LEVELS OF DHA IN MICROALGAE USING MODIFIED AMOUNTS OF CHLORIDE AND POTASSIUM

DSM IP Assets B.V., TE H...

1. A method of producing a biomass comprising docosahexaenoic acid (DHA), comprising:
culturing a heterotrophic microalga in a culture medium to produce said biomass, wherein the culture medium comprises:
chloride ions at a concentration of less than or equal to 2 g/L;
potassium ions at a concentration of greater than or equal to 0.5 g/L; and
a pH less than or equal to 4.5; and
recovering the DHA-containing biomass from the microalga.
US Pat. No. 9,121,013

POLYPEPTIDE HAVING BETA-GLUCOSIDASE ACTIVITY AND USES THEREOF

DSM IP ASSETS B.V., Heer...

1. A variant polypeptide having at least 95% sequence identity with the sequence set out in SEQ ID NO: 2 or the mature form
thereof, wherein said variant polypeptide or mature form thereof has one or more substitutions or insertions relative to SEQ
ID NO: 2 and wherein said variant polypeptide has beta-glucosidase activity.

US Pat. No. 9,045,404

PROCESS FOR THE MANUFACTURE OF 2-PENTYN-1-OL

DSM IP ASSETS B.V., Heer...

1. A process for the manufacture of 2-pentyn-1-ol starting from 2-propyn-1-ol comprising the following steps:
a) preparing a ketal of the formula I starting from 2-propynol in the presence of an acid catalyst;

b) reacting the ketal of formula I with an alkyl halide selected from the group consisting of ethyl chloride, ethyl bromide
and ethyl iodide to the ketal of formula II in the presence of ammonia and a lithium compound selected from the group consisting
of lithium amide, alkyl lithium and aryl lithium;


c) reacting the ketal of the formula II to 2-pentyn-1-ol in the presence of an acid catalyst and a protic solvent;
wherein R1 is H or linear C1-6 alkyl, R2 is linear C1-6 alkyl or branched C3-6 alkyl and R3 is linear C1-6 alkyl.

US Pat. No. 9,309,177

PROCESS FOR PREPARING OR RECOVERING ACETALS OR KETALS BY MEANS OF PERVAPORATION

DSM IP ASSETS B.V., Heer...

1. A process for the preparation of acetals or ketals which comprises:
(i) reacting an aldehyde or ketone with an alcohol in the presence of a solid acid at a reaction temperature of between about
?80° C. to about ?45° C. to form a reaction product mixture, and

(ii) removing water and methanol from the reaction product mixture by pervaporation, wherein
step (ii) includes removing the water from the reaction product mixture by bringing the reaction product mixture into contact
with a first membrane having a flux density for water of 0.04 to 2.8 kg/(hm2), and removing the methanol from the reaction product mixture by bringing the reaction product mixture into contact with
a second membrane having a flux density for methanol of 2.0 to 100 kg/(hm2), and wherein

step (ii) is practiced under a temperature condition of about 60° C. to about 150° C. and under pressure conditions of a pressure
on a retentate side of the membrane of up to 16 bar and a pressure on a permeate side of the membrane of about 1 to 500 mbar.

US Pat. No. 9,133,448

POLYPEPTIDE HAVING CELLOBIOHYDROLASE ACTIVITY AND USES THEREOF

DSM IP ASSETS B.V., Heer...

20. A method for treatment of a substrate comprising plant material, which method comprises contacting the substrate with
a) a polypeptide having at least 95% sequence identity with the sequence set out in SEQ ID NO: 2, or the mature form thereof,
wherein said polypeptide is capable of hydrolysing cellulose; or

(b) a composition comprising a polypeptide having at least 95% sequence identity with the sequence set out in SEQ ID NO: 2,
or the mature form thereof, wherein said polypeptide is capable of hydrolysing cellulose; and a cellulase and/or a hemicellulase
and/or a pectinase.

US Pat. No. 9,079,951

METHOD FOR PRODUCTION OF VITAMIN C

DSM IP ASSETS B.V., Heer...

1. A method for the production of Vitamin C, said method comprising
(a) culturing a recombinant Gluconobacter oxydans in an aqueous medium under conditions that allow direct production of Vitamin C from D-sorbitol or L-sorbose, wherein the
recombinant Gluconobacter oxydans has been transformed with an isolated polynucleotide operably linked to at least one expression control sequence, wherein
the polynucleotide is selected from the group consisting of : (i) a nucleotide sequence encoding the polypeptide as set forth
in SEQ ID NO:2; and (ii) the nucleotide sequence set forth in SEQ ID NO:1; and wherein said polynucleotide is overexpressed
in said Gluconobacter oxydan; and

(b) isolating Vitamin C as product of said culturing; wherein at least 2.8 times more vitamin C is produced as compared to
a wild type Gluconobacter oxydans that do not overexpress said polynucleotide.

US Pat. No. 9,464,023

PROCESS FOR THE PREPARATION OF FORMYLVALERIC ACID AND ADIPIC ACID

DSM IP ASSETS B.V., Heer...

1. Process for the production of 5-formylvaleric acid and adipic acid or esters thereof from an isomeric mixture of pentenoic
acid or esters thereof said mixture comprising at least 4-pentenoic acid or esters thereof, and further comprising 3-pentenoic
acid and/or 2-pentenoic acid or esters thereof, the process comprising:
(a) subjecting the isomeric mixture of pentenoic acid to a hydroformylation reaction comprising a hydroformylation catalyst
which is non-isomerizing towards the pentenoic acid or esters thereof to obtain a mixture comprising 5-formylvaleric acid
or esters thereof and further comprising 3-pentenoic acid and/or 2-pentenoic acid, or esters thereof;

(b) separating the 3-pentenoic acid and/or 2-pentenoic acid, or esters thereof from the 5-formylvaleric acid or esters thereof;
(c) subjecting the separated pentenoic acids or esters thereof to a carbonylation reaction comprising a isomerizing carbonylation
catalyst to obtain adipic acid or esters thereof;

(d) optionally isolating the adipic acid or ester thereof; and
(e) optionally isolating the separated 5-formylvaleric acid or esters thereof.

US Pat. No. 9,296,677

SYNTHESIS OF PERETINOIN

DSM IP ASSETS B.V., Heer...

1. A process for the production of a peretinoin compound of formula (IIIa):

wherein the process comprises the following steps:
(a) reacting a compound of formula (I) or (I?),

wherein
R2 is substituted phenyl, unsubstituted phenyl, —(CH2)3-OH, or —(CH2)3-CH3,

R?2 is OC1-C4 alkyl, and

X is a halogen ion,
with a compound of formula (II)

wherein R1 is H, and

(b) forming the compound of formula (I) or formula (I?) by reacting a compound of formula (IV):

with HX, wherein X is I or Br, and
a compound of formula (V) or formula (V?)

wherein
R2 is phenyl, —(CH2)3—OH, or —(CH2)3—CH3, and

R?2 is OC1-C4 alkyl, wherein

the reactions of steps (a) and (b) are carried out in a one-pot-reaction in the presence of the same inert organic solvent.
US Pat. No. 9,283,549

METAL POWDERDOUS CATALYST COMPRISING A COCRMO-ALLOY

DSM IP ASSETS B.V., Heer...

1. A powderous catalytic system comprising powder particles formed of a metal alloy carrier which is coated by a metal oxide
layer impregnated with Pd particles, wherein the metal alloy carrier comprises:
(i) 55 wt-%-80 wt-%, based on the total weight of the metal alloy, of Co, and
(ii) 20 wt-%-40 wt-%, based on the total weight of the metal alloy, of Cr, and
(iii) 2 wt-%-10 wt-%, based on the total weight of the metal alloy, of Mo.
US Pat. No. 9,283,161

AQUEOUS COSMETIC COMPOSITIONS CONTAINING RESVERATROL SOLUBILIZED IN A LIQUID PHOSPHATE ESTER SURFACTANT

DSM IP ASSETS B.V., Heer...

1. A fluid composition comprising water and a self-emulsifying cosmetic base consisting of resveratrol, 1-45 wt. % of a liquid
trilaureth-4 phosphate surfactant, 15-55 wt. % of at least one cosmetic oil, up to 10 wt. % of remainder ingredients, and
0-20 wt. % of a co-emulsifier.
US Pat. No. 9,254,252

COMPOUNDS

DSM IP ASSETS B.V., Heer...

1. A topical composition comprising resveratrol, wherein the resveratrol is incorporated into a liquid crystal gel network
formed by trilaureth-4 phosphate and a solid co-emulsifier.
US Pat. No. 9,238,218

METAL POWDERDOUS CATALYST FOR HYDROGENATION PROCESS

DSM IP ASSETS B.V., Heer...

1. A powderous catalytic system comprising a carrier formed of a metal alloy comprising:
(i) 45 wt-%-75 wt-%, based on total weight of the metal alloy, of Fe,
(ii) 15 wt-%-30 wt-%, based on total weight of the metal alloy, of Ni,
(iii) 5 wt-%-20 wt-%, based on total weight of the metal alloy, of Co, and
(iv) 3 wt-%-8 wt-%, based on total weight of the metal alloy, of Mo, wherein
the metal alloy is coated by a metal oxide layer impregnated with Pd-nanoparticles.
US Pat. No. 9,090,020

PHOTO-CURABLE RESIN COMPOSITION

DSM IP ASSETS B.V., Heer...

1. A radiation curable composition comprising:
a. from about 50 wt % to about 70 wt % of a cycloaliphatic diepoxide;
b. from about 5 wt % to about 15 wt % of a polyol;
c. from about 5 wt % to about 15 wt % of a monofunctional oxetane having an OH group;
d. from about 10 wt % to about 20 wt % of an aromatic diacrylate selected from the group consisting of a bisphenol A-based
diacrylate, a bisphenol S-based diacrylate, and a bisphenol F-based diacrylate;

e. a radical photoinitiator; and
f. a cationic photoinitiator;
wherein the tensile strength of the cured composition, measured 1 week after UV post-cure in a post-curing apparatus, is from
about 40 MPa to about 75 MPa;

and said radiation curable composition contains greater than 0.10 equivalents of hydroxyl groups per 100 grams of said composition.
US Pat. No. 9,085,782

ENZYMATIC CLEAVAGE OF STEVIOSIDE TO PRODUCE STEVIOL

DSM IP ASSETS B.V., Heer...

1. A method for producing steviol, comprising:
contacting stevioside with an enzyme preparation of pectinases and hemicellulases from Aspergillus niger, and recovering the steviol.

US Pat. No. 9,393,190

METHODS FOR ENHANCING SKIN TAN AND REDUCING RISKS OF UV SKIN DAMAGE

DSM IP ASSETS B.V., Heer...

1. A method of enhancing tanned skin in a human in need thereof by increasing melanin formation in epidermal melanocytes,
wherein the method comprises orally administering to a human in need of increased melanin formation in epidermal melanocytes
a composition comprising steviol and an effective amount of at least one additional ingredient selected from the group consisting
of: lutein, lycopene, astaxanthin, zeaxanthin, ?-carotene, canthaxanthin, L-tyrosine, vitamin E, vitamin D, copper, green
tea extract, lipoic acid, and selenomethionine, wherein the composition is administered daily for at least two weeks, and
wherein the steviol is administered in an amount from 0.01 to 100 mg/kg body weight per day.
US Pat. No. 9,340,699

AQUEOUS OLIGOMER / POLYMER EMULSION WITH CATIONIC FUNCTIONALITY

DSM IP ASSETS B.V., Heer...

1. An aqueous emulsion comprising at least a covalently bound vinyl oligomer and vinyl polymer, wherein said vinyl oligomer
comprises 5 to 85 mol % of vinyl monomers bearing quaternary ammonium ion functional groups and is obtained by a controlled
radical polymerisation of at least one vinyl monomer via a reversible addition-fragmentation chain transfer mechanism in solution
in the presence of a control agent and a source of free radicals; wherein said vinyl polymer is obtained by radical emulsion
polymerisation of vinyl monomers in the presence of the vinyl oligomer; wherein the weight % ratio of vinyl oligomer to vinyl
polymer is in the range of from 0.5:99.5 to 65:35.
US Pat. No. 9,339,449

SHAMPOO PREPARATIONS

DSM IP ASSETS B.V., Heer...

1. A method of treating hair to increase the volume thereof comprising applying a composition to said hair, the composition
comprising an anionic surfactant, an amphoteric or zwitterionic surfactant and an effective amount of a hyperbranched polyesteramide
having at least one quaternized amine end-group, wherein the hyperbranched polyesteramide having at least one quaternized
amine end-group is obtainable by condensation of a dialkylamine of the general formula HN(R1R2) and/or an alcohol functional amines of the general formula HO—R3—N(R1R2), wherein R1 and R2 are di-(C1-20-alkyl)amino-C1-20-alkyl groups or R1 and R2 together form a N-heterocyclic ring and R3 is C1-20-alkyl which optionally also contain oxygen groups, a dicarboxylic acid or a cyclic anhydride thereof and diisopropanolamine
followed by quaternization of the amino groups.
US Pat. No. 9,266,281

PROCESS FOR WELDING OF TWO POLYAMIDE PARTS

DSM IP ASSETS B.V., Heer...

1. A process for welding two polyamide parts comprising forming a welded joint between the two polyamide parts, wherein both
polyamide parts consist of a polyamide composition comprising a polyamide polymer and optionally comprising additives, and
wherein each of the two parts consists of a polyamide composition comprising an iron containing additive, wherein the iron
containing additive is comprised of elementary iron.
US Pat. No. 9,101,917

STRUCTURED CATALYST

DSM IP ASSETS B.V., Heer...

1. A structured catalyst comprising sintered metal fibers (SMF) coated by a basic oxide layer impregnated with Pd-nanoparticles,
wherein the SMF contain an alloy which is free from Al.
US Pat. No. 9,045,785

EICOSAPENTAENOIC ACID-PRODUCING MICROORGANISMS, FATTY ACID COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF

DSM IP Assets B.V., Heer...

1. A method of making a biomass of a microorganism having fatty acids and a concentration of EPA, comprising:
(a) fermenting the microorganism in a fermentor vessel to produce a fermentation broth having an aqueous phase and biomass
wherein the aqueous phase has a dissolved gas wherein the microorganism comprises a Thraustochytrid that produces a biomass
having at least 3% EPA of the total weight of the fatty acids; and

(b) attaining a desired EPA level in the biomass by (i) adjusting the dissolved CO2 to >2% of the dissolved gas, (ii) optionally adjusting the pressure on the biomass, and (iii) optionally adjusting the temperature
in the broth.

US Pat. No. 9,376,563

POLYAMIDE COMPOSITION CONTAINING POLYAMIDE 4,10

DSM IP ASSETS B.V., Heer...

1. A polyamide composition comprising a blend of a first polyamide and a second polyamide, wherein
the first polyamide is selected from the group consisting of polyamide 6 and polyamide 6,6, and is present in the composition
in an amount of at least 50 wt. %, based on total amount of polyamides in the composition, and wherein

the second polyamide consists of polyamide 4,10 and is present in the composition in an amount of 1 wt % to 50 wt %, based
on total amount of polyamides in the composition, and wherein

the second polyamide is present in the composition in an amount sufficient to achieve a reduced fuel permeability rate which
is more than an expected fuel permeability rate based on respective individual fuel permeability rates of the first and second
polyamides when blended.

US Pat. No. 9,434,853

LOW TEMPERATURE HEAT-CURABLE POWDER COATING COMPOSITION COMPRISING A CRYSTALLINE POLYESTER RESIN, AN AMORPHOUS RESIN AND A PEROXIDE

DSM IP ASSETS B.V., Heer...

1. A heat-curable powder coating composition comprising:
i) at least one crystalline polyester resin present in an amount of at least 7.5 wt %;
ii) at least one amorphous polyester resin present in an amount of at most 92.5 wt % ; and
iii) at least one peroxide present in an amount of at least 0.65 parts of peroxide in hundred parts of i)+ii) (pph), wherein,
the composition contains no crosslinking agent; and wherein
the at least one crystalline polyester resin and/or the at least one amorphous polyester resin has 2-butenedioic acid ethylenic
unsaturations, and wherein

the at least one crystalline polyester resin has a melting temperature (Tm) of at least 30° C. and at most 160° C., a theoretical weight per ethylenic unsaturation (WPU) of at least 250 and at most
2000 g/mol and a crystallization temperature (Tc) which is at most 55° C. lower than its Tm; and wherein

if the at least one amorphous polyester resin has 2-butenedioic acid ethylenic unsaturations, then the theoretical weight
per ethylenic unsaturation (WPU) of the at least one amorphous polyester resin is at most 850 g/mol;

each of Tm and Tc is measured via differential scanning calorimetry (DSC); and

the wt % is based on the total amount of i)+ii); and wherein
the peroxide is at least one selected from the group consisting of:
(a) peresters and monopercarbonates according to formula (I)

 wherein
R1 represents an optionally substituted C1-20alkyl, a C6-20aryl or OR5, where R5 represents an optionally substituted C1-20alkyl or an optionally substituted C6-20aryl; and

R2 represents an optionally substituted C1-20alkyl or an optionally substituted C6-20aryl;

(b) peranhydrides of formula (II)

 wherein R3 and R4 each independently stand for an optionally substituted C1-20alkyl, a C6-20aryl or OR6, wherein R6 represents an optionally substituted C1-10alkyl or a C6-20aryl; and

(c) any combination of peroxides according to formula (I) and formula (II) thereof.
US Pat. No. 9,309,150

TWO PART SIZING COMPOSITION FOR COATING GLASS FIBRES AND COMPOSITE REINFORCED WITH SUCH GLASS FIBRES

DSM IP ASSETS B.V., Heer...

1. A pellet comprising glass fibres and a thermoplastic polyester matrix, wherein the glass fibres are at least partially
coated with a two-part sizing composition comprising:
(A) a precursor comprising:
(a) an aminosilane and
(b) a polymer or copolymer containing carboxylic acid and/or anhydride, both having a functionality, F?3, and
(B) a binder comprising a multifunctional epoxy resin of functionality, F?3, and wherein the pellet has been subjected to
a solid state post condensation process (SSPC).

US Pat. No. 9,297,031

PRODUCTION OF CAROTENOIDS IN OLEAGINOUS YEAST AND FUNGI

DSM IP Assets B.V., Heer...

1. An engineered Saccharomyces cerevisiae strain that produces at least one retinolic compound selected from the group consisting of retinol, retinal, retinoic acid,
retinyl palmitate and combinations thereof, the strain comprising at least one retinologenic modification selected from the
group consisting of increased expression or activity of a beta-carotene 15,15?-monooxygenase polypeptide, increased expression
or activity of a retinol dehydrogenase polypeptide, and combinations thereof;
wherein the engineered strain can accumulate lipid to at least about 20% of its dry cell weight; and
wherein as a result of genetic engineering, the engineered strain produces the at least one retinolic compound to a level
at least about 1% of its dry cell weight.

US Pat. No. 9,371,279

TRANSESTERIFICATION PROCESS OF RETINOL ESTERS

DSM IP ASSETS B.V., Heer...

1. A transesterification process for transesterification of a compound of formula (I):

wherein R1 is —CH3,

the process comprises conducting a transesterification reaction under a reduced pressure of 100 to 15000 Pa and a temperature
of between 20° C. and 80° C. by reacting the compound of formula (I) with a compound of formula (II):


wherein
R2 is a C3-C15 alkyl moiety or a C2-C18 alkenyl moiety,

in the presence of NaOH solved in at least one alcohol with a weight ratio of the NaOH to the at least one alcohol being from
1:2 to 1:10 to achieve a transesterification yield of 87.8% or greater.

US Pat. No. 9,255,499

ROTOR FOR VARIABLE VALVE TIMING SYSTEM AND VVT SYSTEM COMPRISING THE ROTOR

DSM IP ASSETS B.V., Heer...

1. A rotor body for a variable valve timing system for an engine, comprising
a main body comprising
a front side for engaging with a front side cover and a back side for engaging with a back side cover,
vanes for defining variable oil or air pressure chambers inside a stator housing, having vane tips for engaging with the stator
housing,

channels for oil or air transport from one pressure chamber to other pressure chambers, and
a central part comprising an (axial) bore hole running from the front side to the back side for receiving a camshaft or a
bolt for fixing to the camshaft,

wherein
the main body is comprised of a fibrous reinforced polymeric material and
the central part comprising the axial bore hole is made of metal,
the rotor body comprises
dynamic sealing elements (i) at the vane tips for engaging with the stator housing, and
dynamic sealing elements (ii) at the front side and the back side for engaging with the front side cover and the back side
cover

wherein the dynamic sealing elements (i) and (ii) are made of a non-reinforced plastic material,
and wherein the metallic central part comprises protrusions protruding into the fibrous reinforced polymeric material and/or
holes filled with a fibrous reinforced material.

US Pat. No. 9,200,636

PLASTIC HOUSING OF A RADIAL FLOW COMPRESSOR

DSM IP ASSETS B.V., Heer...

1. A housing for a radial flow compressor, the housing comprising:
an intake pipe,
a compressor duct,
an outlet pipe, and
a housing body made of a fiber-reinforced thermoplastic polymer composition and comprising at least an upper housing member
and a lower housing member, wherein

the upper and lower housing members are made, assembled together and fixed to each other in an integrated 2-step injection
molding process whereby the upper and lower housing members are formed of a first injection molding shot of the fiber-reinforced
thermoplastic polymer composition so as to define boundary spaces therebetween, and a second injection molding shot of the
fiber-reinforced thermoplastic polymer composition fills the defined boundary spaces between the upper and lower housing members
to thereby integrally fix one to another.

US Pat. No. 9,108,925

PROCESS FOR THE MANUFACTURE OF A PRECURSOR OF VITAMIN B1

DSM IP ASSETS B.V., Heer...

1. A process for the manufacture of Grewe-diamine with purity of at least 94% comprising:
hydrolyzing a compound of the formula II

wherein R is hydrogen or straight- or branched-chain C1-4 alkyl, with an aqueous alkali or alkaline-earth metal hydroxide solution characterized in that the hydrolysis is carried out
in the presence of an organic solvent, and

wherein the products of the hydrolysis are not further purified by sublimation.

US Pat. No. 9,060,945

USE OF DANIELONE AND DERIVATIVES THEREOF IN SKIN CARE

DSM IP ASSETS B.V., Heer...

2. A method of treating pigmentation disorders which comprises topically administering an effective amount of a compound of
formula (1)
formula (1):

wherein,
n is an integer comprised between 1 and 5,
R1 is H or an aliphatic straight or branched carbon chain of 1 to 5 carbon atoms,

R2 and R3 are both independently an aliphatic straight or branched carbon chain of 1 to 6 carbon atoms

to the appropriate skin area of a person in need of such treatment.

US Pat. No. 9,393,311

INTRAVAGINAL RING COMPRISING POLYURETHANE COMPOSITION FOR DRUG DELIVERY

DSM IP ASSETS B.V., Heer...

1. An intravaginal drug delivery ring comprising at least two pharmaceutically active substances wherein the pharmaceutically
active substances are tenofovir and UC781, and
a polyurethane copolymer, wherein the copolymer has the structure according to formula (I):
wherein,
SME1 and SME2 can be the same or different and denote a surface modifying end-group comprising a methylpolyethylene glycyol
(MPEG), having a number average molecular weight ranging from 200 to 8000, linked to the polymer via a urethane or urea bond
resulting from the reaction of an amine- or alcohol-terminated surface modifying end group with an isocyanate group;

SS1, SS2, and SS3 denote soft-segments, wherein
SS 1 is a polyether diol selected from polyethylene oxide (PEO) diol, polytetramethylene oxide (PTMO) diol, polyhexamethylene
oxide diol (PHMO), polypropylene oxide (PPO) diol, copolymer of ethylene glycol and propylene glycol (PEG-co-PPO) diol, and
mixtures thereof;

SS2 is a hydroxyl or amine-terminated silicone polymer having a number average molecular weight ranging from 500 to 5000 g/mol;
and

SS3 is a soft-segment selected from polycarbonate diol and polyester diol, and mixtures thereof;
HS denotes a hard-segment comprising a diisocyanate selected from the group consisting of hexamethylene diisocyanate (HMDI)
and isophorone diisocyanate (IPDI) and combinations thereof,

x, y and z are the same or different and each is an integer equal to or greater than zero and at least two of x, y and z are
not zero; and

wherein the copolymer has a number average molecular weight ranging from 50,000 to 350,000 g/mol and a swollen hardness of
at least 30 A, and

wherein two or more pharmaceutically active substances are homogeneously distributed throughout the polyurethane copolymer.
US Pat. No. 9,307,776

PREGASTRIC ESTERASE AND DERIVATIVES THEREOF

DSM IP ASSETS B.V., Heer...

1. A recombinant polypeptide having lipolytic activity comprising: an amino acid sequence, which is at least 80% homologous
to the amino acid sequence of SEQ ID NO: 2, wherein the amino acid sequence of the recombinant polypeptide comprises, when
compared to SEQ ID NO: 2, amino acid substitutions of A70S, K98N, R158N, R159K, H318N, P320S, and I361T.
US Pat. No. 9,296,917

LOW TEMPERATURE CURE HEAT-CURABLE POWDER COATING COMPOSITION COMPRISING A CRYSTALLINE POLYESTER RESIN, AN AMORPHOUS POLYESTER RESIN, A CROSSLINKING AGENT AND A THERMAL RADICAL INITIATOR

DSM IP ASSETS B.V., Heer...

1. A heat curable powder coating composition comprising:
i) at least one crystalline polyester resin having a melting enthalpy of at least 40 J/g and a crystallization temperature
which is lower than a melting temperature thereof and being at most 55° C. lower than the melting temperature thereof, said
crystalline polyester resin being present in an amount of at most 90 wt %;

ii) at least one amorphous polyester resin having a melting enthalpy lower than 40 J/g; wherein the at least one crystalline
polyester resin and/or the at least one amorphous polyester resin has di-acid ethylenic unsaturations;

iii) at least one crosslinking agent that is either crystalline having a melting enthalpy of at least 40 J/g or amorphous
having a melting enthalpy lower than 40 J/g, said crosslinking agent having reactive unsaturations that are reactable with
the ethylenic unsaturations of the di-acid ethylenic unsaturations of i) and/or ii) and said unsaturations of the crosslinking
agent are different from the unsaturations of i) and ii); and

iv) at least one thermal radical initiator in an amount of at least 0.5 pph, wherein
the wt % is based on the total amount of i)+ii)+iii), and wherein the melting enthalpy, of the at least one crystalline polyester
resin, the melting temperature of the at least one crystalline polyester resin, the melting enthalpy of the at least one amorphous
polyester resin, and the melting enthalpy of the at least one crosslinking agent, is each measured via Differential Scanning
calorimetry (DSC) at a heating rate of 5° C./min, and wherein the crystallization temperature of the at least one crystalline
polyester resin is measured via DSC at a cooling rate of 5° C./min.

US Pat. No. 9,266,814

USE OF NITROOXY ORGANIC MOLECULES IN FEED FOR REDUCING METHANE EMISSION IN RUMINANTS, AND/OR TO IMPROVE RUMINANT PERFORMANCE

DSM IP ASSETS B.V., Heer...

1. A method for reducing the production of methane emanating from the digestive activities of ruminants which comprises orally
administering a sufficient amount of between about 1 mg/kg of feed to about 10 g/kg of feed of at least one organic molecule
or a salt thereof selected from the group consisting of 3-nitrooxypropanol, 5-nitrooxy-pentanenitrile, 5-nitrooxy-pentane,
3-nitrooxy-propyl propionate, 1,3-bis-nitrooxypropane, 1,4-bis-nitrooxybutane, 1,5-bis-nitrooxypentane, 3-nitrooxy-propyl
benzoate, 3-nitrooxy-propyl hexanoate, 3-nitrooxy-propyl 5-nitrooxy-hexanoate, isosorbid-dinitrate, and N-[2-(nitrooxy)ethyl]-3-pyridinecarboxamide,
and bis-(2-nitrooxyethyl) ether.
US Pat. No. 9,260,704

POLYPEPTIDE HAVING OR ASSISTING IN CARBOHYDRATE MATERIAL DEGRADING ACTIVITY AND USES THEREOF

DSM IP ASSETS B.V., Heer...

1. A variant polypeptide having at least 95% sequence identity with the sequence set out in SEQ ID NO: 2 or the mature form
thereof, wherein said variant polypeptide or mature form thereof has one or more substitutions or insertions relative to SEQ
ID NO: 2 and wherein said variant polypeptide has cellulase enhancing activity.
US Pat. No. 9,169,419

POWDER COATING COMPOSITION COMPRISING A POLYESTER AND A ?-HYDROXYALKYLAMIDE AS CROSSLINKER

DSM IP ASSETS B.V., Heer...

1. A thermosetting powder coating composition comprising a crosslinker and a polyester, wherein
the crosslinker is a compound having ?-hydroxyalkylamide groups, and wherein
the polyester is a carboxylic acid functional polyester, and wherein
the polyester has functional groups capable of reacting with ?-hydroxyalkylamide groups, and wherein
the polyester is prepared from at least the following monomers: neopentylglycol, a difunctional alcohol other than neopentyl
glycol (DFA); isophthalic acid (IPA), terephthalic acid (TPA), optionally adipic acid, and a branching monomer selected from
the group consisting of at least trifunctional carboxylic acid, an at least trifunctional alcohol, at least trifunctional
hydroxy carboxylic acid, and mixtures thereof, and wherein

the DFA is present in the polyester from 1 to 50% w/w, and wherein
the IPA is present in the polyester from 6 to 30% w/w, and wherein
the molar ratio of TPA to IPA is at least 1.1, and wherein
the polyester has a functionality of at least 2.1 and at most 4.0, and wherein
the polyester has an acid value of at most 65 mg KOH/g, and wherein
the polyester has a hydroxyl value of at most 14 mg KOH/g, and wherein
the polyester has a glass transition temperature of at least 20° C. and of at most 120° C. measured via DSC at a heating rate
of 5° C./min, and wherein

the polyester has a viscosity of at most 200 Pa·s measured at 160° C. using a cone and plate rheometer Brookfield CAP 2000+
Viscometer with spindle CAP-S-05 at 21 rpm and a shear rate 70 s-1 and wherein

% w/w is based on the polyester.
US Pat. No. 9,302,972

PROCESS FOR THE PREPARATION OF AZELEIC ACID FROM 9-OCTADECENEDIOIC ACID

DSM IP ASSETS B.V., Heer...

1. A process for the preparation of azelaic acid or alkyl azelate starting from mono-unsaturated 9-octadecenedioic acid or
its corresponding alkylester, wherein the process comprises reacting 9-octadecenedioic acid or its corresponding alkylester
in a reaction medium with aqueous hydrogen peroxide in the presence of 10-300 wt. %, based weight % of the 9-octadecanedioic
acid, of an organic carboxylic acid other than 9-octadecene dioic acid and a tungsten-based catalyst to effect cleavage of
the double bond in 9-octadecenedioic acid or the corresponding alkylester.
US Pat. No. 9,180,434

CATALYTIC SYSTEM

DSM IP ASSETS B.V., Heer...

1. A structured catalyst based on sintered metal fibers (SMF) coated by a non-acidic metal oxide layer impregnated with Pd-nanoparticles
and Ag-nanoparticles, wherein a ratio of Pd-nanoparticles: Ag-nanoparticles is 1:1 to 10:1, and wherein the SMF consists of
an alloy free from Al.

US Pat. No. 9,336,964

ELECTRICAL CIRCUIT BREAKER

DSM IP ASSETS B.V., Heer...

1. An electrical circuit breaker comprising an arc formation chamber and an arc extinguishing chamber, the arc formation chamber
being at least partially bounded by a side flange or at least a part of a side wall consisting of a polymeric composition
comprising:
a thermoplastic polymer which comprises a polyamide with a melting temperature of at least 260° C.,
a triazine based flame retardant system comprising 70-100 wt. % of melam relative to the total weight of the flame retardant
system, the flame retardant system being present in an amount such that the melam is present in an amount of at least 20 wt.
% relative to the total weight of the polymeric composition,

at most 0-5 wt. % of phosphorous or halogen containing flame retardants, relative to the total weight of the polymeric composition,
and

0-15 wt. % of a reinforcing agent, relative to the total weight of the polymeric composition.

US Pat. No. 9,227,907

ACID CHLORIDE

DSM IP ASSETS B.V., Heer...

1. A compound of formula (I)

wherein R1 signifies a C1-C15 alkyl moiety or a C2-C18 alkenyl moiety.

US Pat. No. 9,096,633

STABLE NEEDLE-SHAPED CRYSTALS OF NATAMYCIN

DSM IP ASSETS B.V., Heer...

1. Needle shaped crystals of ?-natamycin produced by a method comprising dissolving ?-natamycin in an aqueous solution comprising
at least 90% water, at a pH of below 4 or at a pH ranged between 11 to 14, and then bringing the pH to neutral conditions,
which are needle shaped crystals having a mean length of between 0.1 and 20 ?m.
US Pat. No. 9,463,609

PROCESS FOR PRODUCING MULTILAYER BLOWN FILM AND FILM OBTAINED BY THE PROCESS

DSM IP ASSETS B.V., Heer...

1. A process for producing by blown film process a multilayer film containing at least one copolyamide layer and at least
one polyolefin layer, wherein a copolyamide is employed comprising monomeric units of:
(i) aliphatic non-cyclic diamines X and aliphatic non-cyclic dicarboxylic acids Y or aliphatic non-cyclic ?,?-amino acids
Z, and

(ii) cyclic diamines M and cyclic diacids N in a total amount between 0.1 and less than 1.8 wt % based on the total amount
of copolyamide.

US Pat. No. 9,353,387

DICARBOXYLIC ACID PRODUCTION PROCESS

DSM IP ASSETS B.V., Heer...

1. A process for the production of a dicarboxylic acid and ethanol which comprises fermenting a genetically modified yeast
in a fermentation medium under anaerobic conditions at a pH value of between 1 and 5 and producing the dicarboxylic acid and
ethanol, wherein the dicarboxylic acid is selected from the group consisting of: malic acid, fumaric acid, and succinic acid,
and wherein the genetically modified yeast is transformed with at least one nucleotide encoding an enzyme expressed in the
cytosol selected from the group consisting of: phosphoenol pyruvate carboxykinase, malate dehydrogenase, fumarase, and fumarate
reductase.
US Pat. No. 9,410,175

PROCESS FOR MICROBIAL PRODUCTION OF A VALUABLE COMPOUND

DSM IP ASSETS B.V., Heer...

1. A process for the increased production of an enzyme comprising:
(a) cultivating a filamentous fungus belonging to the species Aspergillus niger in a culture broth in a cultivation process that comprises: i) a cultivating growth phase wherein filamentous fungal biomass
is formed and ii) a cultivating production phase wherein the enzyme is produced by the filamentous fungal biomass,

wherein said cultivating growth phase is conducted in the presence of all filamentous fungal nutrients in an amount sufficient
to avoid the establishment of a nutrient limitation in the growth of the filamentous fungus, wherein the filamentous fungal
nutrients comprise a carbon source, a nitrogen source as well as additional compounds required for growth of the filamentous
fungus and/or the production of the enzyme, wherein said additional compounds comprise phosphate, sulfate, trace elements
and/or vitamins and said cultivating production phase is conducted in the presence of all filamentous fungal nutrients except
oxygen in an amount sufficient to avoid the establishment of a limitation of nutrients other than oxygen in the production
phase, and

wherein the cultivating production phase is conducted in the presence of an amount of oxygen suitable to establish and maintain
conditions of oxygen limitation during the cultivating production phase, wherein the suitable amount of oxygen is fed to the
culture broth during the cultivating production phase to ensure that the oxygen transfer rate (OTR) of the culture broth is
identical to the oxygen uptake rate (OUR) of the culture broth with a deviation of plus or minus 10%, and wherein the suitable
amount of oxygen is fed to the culture broth to further ensure that the OTR is as high as possible; and

(b) recovering from the culture broth the enzyme obtained in the cultivating production phase, said enzyme yield obtained
in the cultivating production phase being greater than obtainable by a similar process wherein said cultivating production
phase is conducted under conditions such that all nutrients including oxygen are provided to the culture broth in an amount
sufficient to avoid the establishment of a limitation of nutrients.

US Pat. No. 9,309,194

INTERMEDIATES FOR THE VITAMIN A AND ?-CAROTENE SYNTHESIS

DSM IP ASSETS B.V., Heer...

1. A compound of formula (I):

wherein R1 signifies a C1-C15 alkyl moiety or a C2-C18 is alkenyl moiety.

US Pat. No. 9,221,999

METHOD TO ACTIVATE SILICONE RUBBER SURFACES

DSM IP ASSETS B.V., Heer...

1. A method for activating silicone rubber surfaces comprising steps of:
i) swelling at least a surface of a silicone rubber matrix with a silicone rubber swelling solvent;
ii) treating the silicone rubber matrix during or after the swelling with a solution comprising at least a reactive silane,
wherein the reactive silane comprises at least one hydrolytically labile bond linked to at least one of the Si atoms present
in the reactive silane, the reactive silane comprising a reactive silane according to Formula (III), Formula (IV), or Formula
(V), thereby forming a treated silicone rubber matrix; and

iii) drying and/or heat treating the treated silicone rubber matrix, wherein
Formula (III) is:

wherein R9 and R10 are independently selected from the group consisting of branched and linear, substituted and unsubstituted
alkyl, alkenyl, and alkoxy groups; and wherein R11 is selected from the group consisting of substituted and unsubstituted,
saturated and unsaturated, branched and linear aliphatic hydrocarbon groups, substituted and unsubstituted, branched and linear
aralkyl groups, substituted and unsubstituted aryl groups, and hydrogen;

Formula (IV) is:

wherein each R11 may be the same or different and is selected from the group consisting of substituted and unsubstituted,
saturated and unsaturated, branched and linear aliphatic hydrocarbon groups, substituted and unsubstituted, branched and linear
aralkyl groups, substituted and unsubstituted aryl groups, and hydrogen; and R12 and R13 may be the same or different and
are selected from the group consisting of substituted and unsubstituted, branched and linear alkyl and alkoxy groups; and

Formula (V) is:

wherein R14 is selected from the group consisting of hydrogen, saturated and unsaturated, substituted and unsubstituted aliphatic
hydrocarbon groups, and substituted and unsubstituted aryl groups; and R15 is selected from substituted and unsubstituted,
branched and linear alkyl groups.

US Pat. No. 9,198,452

PROCESS FOR FOOD PRODUCTION

DSM IP ASSETS B.V., Heer...

1. A process for whitening whey containing annatto comprising contacting a whey containing annatto with a beta-carotene converting
enzyme obtained from Marasmius scorodonius under conditions such that said whey containing annatto is whitened.
US Pat. No. 9,194,059

PROCESS FOR SPINNING UHMWPE, UHMWPE MULTIFILAMENT YARNS PRODUCED THEREOF AND THEIR USE

DSM IP ASSETS B.V., Heer...

1. A gel-spinning process for making ultrahigh molecular weight polyethylene (UHMWPE) yarns comprised of UHMWPE gel-spun filaments,
wherein the process comprises the steps of:
a) preparing a solution of an UHMWPE in a solvent;
b) spinning through a spinneret and into an air gap the solution of step a) to form fluid filaments, the spinneret containing
multiple spinholes and wherein each spinhole comprises at least one zone with a gradual decrease in diameter and wherein the
downstream diameter of the spinhole from which the solution is issued in the air gap is between 0.1 and 1.5 mm;

c) drawing the fluid filaments with a fluid draw ratio DRfluid=DRsp×DRag, wherein DRsp and DRag are the draw ratios in the spinholes and in the air gap, respectively, wherein the fluid filaments are drawn with a fluid
draw ratio DRfluid of 450-1200, provided that DRag is at least 50, and with an overall draw ratio DRoverall of 12000-50000, wherein DRoverall=DRfluid×DRgel×DRsolid where DRfluid is the fluid draw ratio of the fluid filaments, DRgel is a draw ratio of the gel filaments and DRsolid is a draw ratio of the solid filaments;

d) cooling the fluid filaments to form solvent-containing gel filaments; and
e) removing at least partly the remaining solvent from the gel filaments to form solid filaments, before, during or after
drawing the solid filaments with a draw ratio DRsolid of at least 4 and thereby obtain a UHMWPE yarn having a tensile strength of 3.5-5.5 GPa comprised of UHMWPE filaments of 0.06-0.5
dtex.

US Pat. No. 9,316,465

METHOD AND DEVICE FOR PRODUCING A POLYMER TAPE

DSM IP ASSETS B.V., Heer...

1. A method for producing a highly oriented non-fibrous polymer tape comprising:
a) forming and compressing a polymer powder bed at a temperature below the melting point of the polymer to form a non-fibrous
polymeric sheet;

b) rolling and stretching the non-fibrous sheet formed according to step a) in a calendar unit at a temperature below the
melting point of the polymer to form a partially oriented polymer web;

c) drawing the partially oriented polymer web in a drawing unit at a temperature below the melting point of the polymer to
form an oriented non-fibrous polymer tape; and

d) repeating step c) to form a more oriented non-fibrous polymer tape, wherein
the method is practiced in a discontinuous manner such that an ingoing line speed of at least two of the method steps b),
c) and d) are lower than an outgoing line speed of a preceding step.

US Pat. No. 9,303,253

METABOLIC ENGINEERING OF ARABINOSE-FERMENTING YEAST CELLS

DSM IP ASSETS B.V., Herl...

1. A eukaryotic cell capable of expressing the following nucleotide sequences, wherein the expression of these nucleotide
sequences confers on the cell the ability to use L-arabinose and/or to convert L-arabinose into L-ribulose, and/or xylulose
5-phosphate and/or into a desired fermentation product:
(a) a nucleotide sequence encoding an arabinose isomerase (araA), wherein said nucleotide sequence is selected from the group
consisting of:

i. nucleotide sequences encoding an araA, said araA comprising an amino acid sequence that has at least 90% sequence identity
with the amino acid sequence of SEQ ID NO:1,

ii. nucleotide sequences comprising a nucleotide sequence that has at least 90% sequence identity with the nucleotide sequence
of SEQ ID NO:2,

iii. nucleotide sequences the complementary strand of which hybridizes to a nucleic acid molecule of sequence of (i) or (ii)
under moderate conditions;

(b) a nucleotide sequence encoding a L-ribulokinase (araB), wherein said nucleotide sequence is selected from the group consisting
of:

i. nucleotide sequences encoding an araB, said araB comprising an amino acid sequence that has at least 90% sequence identity
with the amino acid sequence of SEQ ID NO:3,

ii. nucleotide sequences comprising a nucleotide sequence that has at least 90% sequence identity with the nucleotide sequence
of SEQ ID NO:4,

iii. nucleotide sequences the complementary strand of which hybridizes to a nucleic acid molecule of sequence of (i) or (ii)
under moderate conditions;

(c) a nucleotide sequence encoding an L-ribulose-5-P-4-epimerase (araD), wherein said nucleotide sequence is selected from
the group consisting of:

i. nucleotide sequences encoding an araD, said araD comprising an amino acid sequence that has at least 90% sequence identity
with the amino acid sequence of SEQ ID NO:5,

ii. nucleotide sequences comprising a nucleotide sequence that has at least 90% sequence identity with the nucleotide sequence
of SEQ ID NO:6,

iii. nucleotide sequences the complementary strand of which hybridizes to a nucleic acid molecule of sequence of (i) or (ii)
under moderate conditions;

wherein moderate conditions is defined as conditions that allow a nucleic acid sequences of at least 50 nucleotides to hybridize
at a temperature of about 45° C. in a solution comprising about 1 M salt and washing at room temperature in a solution comprising
about 1 M salt.

US Pat. No. 9,422,270

MELAM GRANULATE MATERIAL AND PROCESS FOR PREPARATION THEREOF

DSM IP ASSETS B.V., Heer...

1. A process for the preparation of a melam granulate material, the process comprising steps of:
(i) preparing an aqueous slurry from a freshly prepared moist melam having a water content of at least 8 wt. %, relative to
the total weight of the moist melam, the slurry comprising water, melam and a water soluble polymeric binding agent, wherein
the melam is present in an amount of 5-35 wt. % relative to the total weight of the slurry, and the water soluble polymeric
binding agent is present in an amount of 0.5-8 wt. % relative to the total amount of melam and the water soluble polymeric
binding agent;

(ii) drying the slurry in fluid bed to form a granulate material consisting of granules comprised of melam particles bonded
to each other with the polymeric binding agent, wherein the granules have a median particle size (d50) in a range of 100-1000
?m; and

(iii) collecting the resulting granulate material.
US Pat. No. 9,290,629

PROCESS FOR PRODUCING HIGH MOLECULAR WEIGHT POLYETHYLENE

DSM IP ASSETS B.V., Heer...

18. An artificial medical implant comprising (U)HMWPE and a stabilizer consisting of at least one Hindered Amine Light Stabilizer
selected from the group consisting of 2,2,6,6-tetramethyl-4-piperidone; 2,2,6,6-tetramethyl-4-piperidinol; bis-(1,2,2,6,6-pentamethylpiperidyl)-(3?,5?-di-tert-butyl-4?-hydroxybenzyl)
butylmalonate; di-(2,2,6,6-tetramethyl-4-piperidyl) sebacate; oligomer of N-(2-hydroxyethyl)-2,2,6,6-tetramethyl-4-piperidinol
and succinic acid; bis-(2,2,6,6-tetramethyl-4-piperidinyl) succinate; bis-(1-octyloxy-2,2,6,6-tetramethyl-4-piperidinyl) sebacate;
bis-(1,2,2,6,6-pentamethyl-4-piperidinyl) sebacate; N,N?-bis-(2,2,6,6-tetramethyl-4-piperidyl) hexane-1,6-diamine; N-butyl-2,2,6,6-tetramethyl-4-piperidinamine;
2,2?-[(2,2,6,6-tetramethylpiperidinyl)imino]-bis-[ethanol]; poly((6-morpholine-S-triazine-2,4-diyl)(2,2,6,6-tetramethyl-4-piperidinyl)-iminohexamethylene-(2,2,6,6-tetramethyl-4-piperidinyl)-imino);
5-(2,2,6,6-tetramethyl-4-piperidinyl)-2-cycloundecyloxazole); 8-acetyl-3-dodecyl-7,7,9,9-tetramethyl-1,3,8-triazaspiro(4,5)decane-2,4-dione;
polymethylpropyl-3-oxy[4(2,2,6,6-tetramethyl)piperidinyl)siloxane; copolymer of ?-methylstyrene-N-(2,2,6,6-tetramethyl-4-piperidinyl)maleimide
and N-stearylmaleimide; 1,2,3,4-butanetetracarboxylic acid, polymer with beta,beta,beta?,beta?-tetramethyl-2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diethanol,
1,2,2,6,6-pentamethyl-4-piperidinyl ester; 2,4,8,10-tetraoxaspiro[5.5]undecane-3,9-diethanol,beta,beta,beta?,beta?-tetramethyl-,
polymer with 1,2,3,4-butanetetracarboxylic acid, 2,2,6,6-tetramethyl-4-piperidinyl ester; D-glucitol, 1,3:2,4-bis-O-(2,2,6,6-tetramethyl-4-piperidinylidene)-;
oligomer of 7-oxa-3,20-diazadispiro[5.1.11.2]heneicosan-21-one,2,2,4,4-tetramethyl-20-(oxiranylmethyl); propanedioic acid,
[(4-methoxyphenyl)methylene]-,bis(1,2,2,6,6-pentamethyl-4-piperidinyl) ester; formamide, N,N?-1,6-hexanediylbis[N-(2,2,6,6-tetramethyl-4-piperidinyl;
1,3,5-triazine-2,4,6-triamine, N,N??-[1,2-ethanediylbis ff[4,6-bis[butyl(1,2,2,6,6-pentamethyl-4-iperidinyl)amino]-1,3,5-triazine-2-yl]imino]-3,1-propanediyl]]bis[N?,N?-dibutyl-N?,N?-bis(1,2,2,6,6-pentamethyl-4-piperidinyl);
1,5-dioxaspiro (5,5) undecane 3,3-dicarboxylic acid, bis (2,2,6,6-tetramethyl-4-piperidinyl) ester; 1,5-dioxaspiro (5,5) undecane
3,3-dicarboxylic acid, bis (1,2,2,6,6-pentamethyl-4-peridinyl) ester; N-2,2,6,6-tetramethyl-4-piperidinyl-N-amino-oxamide;
4-acryloyloxy-1,2,2,6,6-pentamethyl-4-piperidine; 1,3-benzenedicarboxamide,N,N?-bis(2,2,6,6-tetramethyl-4-piperidinyl); 3-dodecyl-1-(2,2,6,6-tetramethyl-4-piperidyl)-pyrrolidin-2,5-dione;
1,3-Propanediamine, N,N-1,2-ethanediylbis-,polymer with 2,4,6-trichloro-1,3,5-triazine, reaction products with N-butyl-2,2,6,6-tetramethyl-4-piperidinamine;
1,1?-(1,2-ethane-di-yl)-bis-(3,3?,5,5?-tetra-methyl-piperazinone); 1,1?,1?-(1,3,5-triazine-2,4,6-triyltris ((cyclohexylimino)-2,1-ethanediyl)tris(3,3,5,5-tetramethylpiperazinone);
1,1?,1?-(1,3,5-triazine-2,4,6-triyltris((cyclohexylimino)-2,1-ethanediyl)tris(3,3,4,5,5-tetramethylpiperazinone); 1,2,3,4-Butanetetracarboxylic
acid, tetrakis(2,2,6,6-tetramethyl-4-piperidinyl) ester; 1,2,3,4-Butane-tetra-carboxylic acid, 1,2,3-tris-(1,2,2,6,6-penta-methyl-4-piperidyl)-4-tridecylester;
mixture of esters of 2,2,6,6-tetra-methyl-4-pipiridinol and several fatty acids; Propanedioic acid, [(4-methoxyphenyl)methylene]-,bis(2,2,6,6-tetramethyl-4-piperidinyl)
ester; 3-Dodecyl-1-(2,2,6,6-tetramethyl-4-piperidyl)-pyrrolidin-2,5-dione; 3-Dodecyl-1-(1,2,2,6,6-pentamethyl-4-piperidyl)-pyrrolidin-2,5-dione;
1,2,3,4-Butanetetracarboxylic acid, tetrakis(1,2,2,6,6-pentamethyl-4-piperidinyl)ester; 1,2,3,4-Butane-tetra-carboxylic acid,
1,2,3-tris-(2,2,6,6-tetra-methyl-4-piperidyl)-4-tridecylester; mixture of: 2,2,4,4 tetramethyl-21-oxo-7-oxa-3.20-diazadispiro[5.1.11.2]-heneicosane-20-propionic
acid dodecylester and 2,2,4,4 tetramethyl-21-oxo-7-oxa-3.20-diazadispiro[5.1.11.2]-heneicosane-20-propionicacid tetradecylester;
Poly[[6-[(1,1,3,3-tetramethylbutyl)amino]-s-triazine-2,4-diyl][2,2,6,6-tetramethyl-4-piperidinyl)-imino]hexamethylene[(2,2,6,6-tetramethyl-4-piperidinyl)imino]]};
1,3,5-Triazine-2,4,6-triamine, N,N??-[1,2-ethanediylbis[[[4,6-bis[butyl(1,2,2,6,6-pentamethyl-4-piperidinyl)amino]-1,3,5-triazine-2-yl]imino]-3,1-propanediyl]]-bis[N?,N?-dibutyl-N?,N?-bis(1,2,2,6,6-pentamethyl-4-piperidinyl);
Poly[(6-morpholino-s-triazine-2,4-diyl)[1,2,2,6,6-penta-methyl-4-piperidyl)imino]-hexamethylene[(1,2,2,6,6 penta-methyl-4-piperidyl)iminol]1,6-Hexanediamine,
N,N?-bis(1,2,2,6,6-pentamethyl-4-pipiridinyl)-, Polymers with morpholine-2,4,6-trichloro-1,3,5-triazine; Poly-methoxypopyl-3-oxy[4(1,2,2,6,6-pentamethyl)-piperidinyl]-siloxane;
1,6-Hexanediamine, N,N?-bis(2,2,6,6-tetramethyl-4piperidinyl)-polymer with 2,4,6-trichloro-1,3,5-triazine, reaction products
with N-butyl-1-butanamine and N-butyl-2,2,6,6-tetramethyl-4-piperidinamine; reaction products of N,N?-ethane-1,2-diylbis (1,3-propanediamine),
cyclohexane, peroxidized 4-butylamino-2,2,6,6-tetramethylpiperidine and 2,4,6-trichloro-1,3,5- triazine; and 1,6-hexanediamine,
N,N?-bis(2,2,6,6-tetramethyl-4-piperidinyl)-, polymer with 2,4,6-trichloro-1,3,5-triazine, reaction products with 3-bromo-1-propene,
n-butyl-1- butanamine and N-butyl-2,2,6,6-tetramethyl-4-piperidinamine, oxidized, hydrogenated, wherein Hindered Amine Light
Stabilizers are the only stabilizers in the artificial medical implant, wherein the artificial medical implant has a cross-link
density of 0.09 mol/dm3 or more.

US Pat. No. 9,260,801

PROCESS FOR REMOVING RESIDUAL SPIN SOLVENT FROM A GEL SPUN FILAMENT, THE FILAMENT, MULTI-FILAMENT YARN AND PRODUCTS COMPRISING THE FILAMENT

DSM IP ASSETS B.V., Heer...

1. A process for removal of residual spin solvent from a gel spun ultrahigh molecular weight polyethylene (UHMwPE) filament
comprising the steps of:
(a) providing a gel spun UHMwPE filament having an effective diameter of above 16 ?m and a residual spin solvent content of
between 100 and 2000 ppm,

(b) winding the gel spun UHMwPE filament provided by step (a) around a frame so that the filament is taut around the frame
at a tension of more than 0.15 g/dtex, and subsequently

(c) placing the frame with the filament wound taut therearound according to step (b) in an autoclave and removing residual
spin solvent from the filament by subjecting the filament taut to super critical CO2 extraction in the autoclave at a temperature between 80° C. and 147.5° C. and at a pressure between 50 bar and 400 bar for
a time period between half an hour and 24 hours to thereby obtain a UHMwPE filament with residual spin solvent content of
below 100 ppm.

US Pat. No. 9,518,102

POLYPEPTIDE FOR IMPROVING PROTEIN PRODUCTION IN MICROORGANISMS OF THE PHYLUM LABYRINTHULOMYCOTA

DSM IP Assets B.V., Heer...

1. A recombinant nucleic acid molecule encoding a fusion protein, or the complementary sequence thereof, comprising:
(a) (i) a polynucleotide sequence encoding a polypeptide, wherein the polypeptide comprises an amino acid sequence having
at least 90% sequence identity to the amino acid sequence of SEQ ID NO: 15 or a fragment thereof, wherein the amino acid sequence
or fragment thereof functions as a signal peptide, and (ii) a polynucleotide encoding a second polypeptide that is a protein,
wherein the polynucleotide encoding the signal polypeptide is operably linked to the polynucleotide encoding the protein;
or

(b) a polynucleotide sequence that is fully complementary to the polynucleotide sequence of (a).

US Pat. No. 9,340,750

PROCESS FOR THE MANUFACTURE OF METHYL LIMONITRILE

DSM IP ASSETS B.V., Heer...

1. A process for the manufacture of methyl limonitrile comprising a mixture of 3,7-dimethyl-2,6-nonadiene nitrile, 3,7-dimethyl-3,6-nonadiene
nitrile and 7-methyl-3-methylene-6-nonene nitrile, wherein the process comprises the following steps:
a) reacting 6-methyl-5-octen-2-one with cyano acetic acid and removing carbon dioxide and water, wherein the reaction and
the removal of carbon dioxide and water are performed in the presence of pyridine as a base and 1,4-diamino butane as a co-base
in an organic solvent, and wherein the organic solvent is a solvent which forms a heteroazeotrop with water;

b) removing the solvent and pyridine of the reaction mixture obtained after having performed step a) or step c) by distillation
to obtain a reaction mixture;

c) isomerizing the reaction mixture obtained after having performed step a) or step b) to obtain an isomerized reaction mixture;
wherein

step b) can be performed before or after step c).
US Pat. No. 9,334,504

HIGH THROUGHPUT TRANSFECTION OF FILAMENTOUS FUNGI

DSM IP ASSETS B.V., Heer...

1. A high throughput method for transfection of filamentous fungal cells, comprising:
(a) providing a multitude of containers;
(b) filling into each container an amount of polymer needed for the transfection;
(c) filling the cells to be transfected as well as an aqueous solution of transfection reagent into each of the containers;
(d) incubating the resulting mixture;
(e) optionally removing the transfection reagent from the incubated mixture; and
(f) selecting the cells which have been transformed,characterized in that the total volume of the incubating mixture is less than 1 ml per container, wherein said polymer of
step (b) is DNA or RNA, and wherein said transfection reagent of step (c) is polyethylene glycol 4000, and wherein the aqueous
solution of step (c) contains not more than 30% of polyethylene glycol.

US Pat. No. 9,255,171

POLYMER, PROCESS AND COMPOSITION

DSM IP ASSETS B.V., Heer...

1. An oligomer-polymer composition comprising an oligomer composition O having a weight average molecular weight of from 1000
to 150,000 g/mol (measured by GPC), and a polymer composition P having a weight average molecular weight of at least 80,000
g/mol (measured by GPC), wherein the oligomer composition O and the polymer composition P each independently comprise a copolymer
comprising:
(a) optionally at least 23% by weight of at least one monomer represented by Formula 1:

 where both R1 and R2 independently represent an optionally substituted hydrocarbo moiety having from 4 to 10 carbon atoms,

(b) optionally at least one hydrophilic monomer in an amount sufficient that the resultant copolymer has an acid value less
than 150 mg KOH per g of polymer,

(c) optionally of one or more monomers represented by Formula 2:

 where R3 and R4 independently represent H or an optionally substituted hydrocarbo moiety having from 1 to 20 carbon atoms

 X1 and X2 independently represents O or NR5 where R5 denotes H or an optionally substituted hydrocarbo moiety having from 1 to 20 carbon atoms

 with the proviso that when X1 and/or X2 are O then the respective R3 and/or R4 attached to the oxy group independently represent an optionally substituted hydrocarbo having from 1 to 3 carbon atoms

(d) optionally less than 77% by weight of monomers other than components (a), (b) or (c),
where the percentages or amounts of (a), (b) (c) (d) are by weight calculated as a proportion of the total weight of (a)+(b)+(c)+(d)
and thus total 100%;

where independently at least one of the components (a), (b), (c), (d) and the copolymer obtained from components (a), (b),
(c) and/or (d) is biorenewable as defined by an amount of carbon-14 sufficient to produce a decay of at least about 1.5 disintegrations
per minute per gram carbon (dpm/gC); and

where at least one component (a) is present in either oligomer composition O or polymer composition P, and wherein the oligomer-polymer
composition comprises:

(a) component (a) in an amount from 24% to 70% by weight being one or more monomers represented by Formula 1
(b) component (b) being one or more acid functional monomer(s) in an amount from 0.5% to 15% by weight, in an amount also
sufficient that the resultant copolymer has an acid value of from 3 to 100 mg KOH per g of polymer,

(c) component (c) in an amount from 0.01% to 10% by weight being one or more monomers represented by Formula 2 in which X1 and X2 are both O and R3 and/or R4 independently represent an optionally substituted hydrocarbo having from 1 to 3 carbon atoms,

(d) component (d) if present in an amount less than 75% by weight of monomer(s) other than components (a), (b) or (c) not
containing styrene, butyl acrylate, 2-ethyl hexyl acrylate and/or mixtures thereof; and

with the provisos that
where the copolymer is prepared by an emulsion polymerisation a chaser monomer is not used;
the copolymer is not prepared in the presence of a seed polymer comprising a poly(itaconate ester);
the copolymer is not prepared in the presence of an initiator system comprising an organoborane amine complex.
US Pat. No. 9,241,938

TRIGONELLINE AS A MUSCLE STIMULANT

DSM IP ASSETS B.V., Heer...

1. A method of increasing muscle mass in a human in need thereof in combination with decreasing the amount of muscle mass
lost during time of lesser muscle activity in a human in need thereof comprising administering to the human in need thereof
a therapeutically effective amount of synthetic trigonelline and/or salt or ester thereof to effectively increase muscle mass
in the human in need thereof in combination with decreasing the amount of muscle mass lost during time of lesser muscle activity
in the human in need thereof, wherein said human is doing body building or weight training.
US Pat. No. 9,200,164

COATING SYSTEM

DSM IP ASSETS B.V., Heer...

1. A coating system comprising:
(i) a lipid compound which is at least one selected from the group consisting of stearic acid, palmitic acid and salts thereof,
(ii) at least one film forming compound and/or at least one emulsifier, and
(iii) at least one plasticizer, wherein
the lipid compound has a mass median diameter of less than 1 ?m.

US Pat. No. 9,181,163

HYDROGENATION OF KETONES HAVING AT LEAST A CARBON-CARBON DOUBLE BOND IN THE ?,?-POSITION

DSM IP ASSETS B.V., Heer...

1. A process for hydrogenation of ketones having at least a carbon-carbon double bond in the ?,?-position to the keto group
by hydrogen in the presence of at least one chiral iridium complex of formula (I)

wherein
n is 1 or 2;
X1 and X2 are independently from each other hydrogen atoms, C1-4-alkyl, C5-7-cycloalkyl, adamantyl, phenyl (optionally substituted with one to three C1-5-alkyl, C1-4-alkoxy, C1-4-perfluoroalkyl groups and/or one to five halogen atoms)), benzyl, 1-naphthyl, 2-naphthyl, 2-furyl or ferrocenyl;

Z1 and Z2 are independently from each other hydrogen atoms, C1-5-alkyl or C1-5-alkoxy groups;

Y is an anion selected from the group consisting of halide, PF6?, SbF6?, tetra(3,5-bis(trifluoromethyl)phenyl)borate(BArF?), BF4?, perfluorinated sulfonates, preferably F3C—SO3? or F9C4—SO3?; ClO4?, Al(OC6F5)4?, Al(OC(CF3)3)4?, N(SO2CF3)2?N(SO2C4F9)2? and B(C6F5)4?;

R1 represents a group of formula (II) or (III) or (IV):


wherein R2 and R3 represent either both H or an C1-C4-alkyl group or represent a divalent group forming together a 6-membered cycloaliphatic or an aromatic ring which optionally
is substituted by halogens atoms or by C1-C4-alkyl groups or by C1-C4-alkoxy groups;

R4 and R5 represent a divalent group forming together a 6-membered cycloaliphatic or an aromatic ring which optionally is substituted
by halogens atoms or by C1-C4-alkyl groups or by C1-C4-alkoxy groups;

R6 and R7 and R8 represent each a C1-C4-alkyl group;

R9 and R10 represent a divalent group forming together a 6-membered cycloaliphatic or an aromatic ring which optionally is substituted
by halogens atoms or by C1-C4-alkyl groups or by C1-C4-alkoxy groups; and wherein

* represents the chiral centre of the catalyst of formula (I); and
the dotted line represents the bond by which formula (II) or (III) or (IV) is bound to the rest of formula (I).
US Pat. No. 9,381,489

DEVICE USEFUL FOR HYDROGENATION REACTIONS (I)

DSM IP ASSETS B.V., Heer...

1. A device for treatment of material transported through the device comprising at least one porous element which allows cross-flow
of material through the device, wherein
the at least one porous element consists of a solid metallic structure which is coated by a non-acidic metal oxide layer impregnated
with Pd-nanoparticles having an average particle size of between 0.5 and 20 nm, and wherein

the at least one porous element is formed of a metal alloy comprising:
(i) 60 wt-%-80 wt-%, based on total weight of the metal alloy, of Fe,
(ii) 1 wt-%-30 wt-%, based on total weight of the metal alloy, of Cr, and
(iii) 0.5 wt-%-10 wt-%, based on total weight of the metal alloy, of Ni.
US Pat. No. 9,382,521

POLYUNSATURATED FATTY ACID PRODUCTION IN HETEROLOGOUS ORGANISMS USING PUFA POLYKETIDE SYNTHASE SYSTEMS

DSM IP Assets B.V., TE H...

1. A recombinant vector comprising a nucleic acid sequence encoding a protein with triacylglycerol (TAG) synthesis activity,
wherein the protein comprises an amino acid sequence that is at least 95% identical to the amino acid sequence of SEQ ID NO:
101.

US Pat. No. 9,320,688

POWDEROUS FORMULATIONS OF ORGANIC ACIDS OR ESTERS HAVING AN AROMATIC RING SYSTEM

DSM IP ASSETS B.V., Heer...

1. A powderous formulation comprising
(i) 0.5 to 60 wt-%, based on the total weight of the powderous formulation, of at least one compound of formula (I)

wherein
X is —N— or CH— and
R1 is H or a C1-C4 alkyl moiety, and
(ii) 0.5-50 wt-%, based on the total weight of the powderous formulation, of an auxiliary compound having an average particle
size (d 0.5) in the powderous formulation of 10 ?m to 100 ?m, wherein the auxiliary compound is a least one selected from
the group consisting of aluminum ammonium sulphate, aluminum potassium sulfate, ammonium acetate, ammonium bisulphite, ammonium
carbonate, ammonium chloride, ammonium dihydrogen phosphate, ammonium hydrogen carbonate, bentonite, montmorillonite, calcium
aluminates, calcium carbonate, calcium silicate, synthetic calcium sulphate dihydrate, calcium sulfate, kaolinitic clays,
diatomaceous earth, perlite, potassium bisulphite, potassium hydrogen carbonate, potassium sulphate, potassium carbonate,
sepiolitic clays, silicic acid, synthetic sodium aluminosilicate, sodium aluminosulfate, sodium bisulphate, sodium carbonate,
sodium chloride, sodium hydrogen carbonate, sodium sulphate, vermiculite, calcium carbonate, magnesium carbonate, calcareous
marine algae, magnesium oxide, magnesium sulphate, dicalcium phosphate, tri-calcium phosphate, mono-dicalcium phosphate, defluorinated
rock-phosphate, monocalcium phosphate, calcium-magnesium phosphate, mono-ammonium phosphate, magnesium phosphate, sodium-calcium-magnesium
phosphate, mono-sodium phosphate, glycerol, propylene glycol, glyceryl triacetate , sorbitol, polydextrose, lactic acid and
urea, and

(iii) up to 40 wt-%, based on the total weight of the powderous formulation, of a carrier material
(iv)the formulation having MIE values of 10-1000 mJ.
US Pat. No. 9,506,168

COLORED SUTURE

DSM IP ASSETS B.V., Heer...

1. A colored suture consisting of multi-filamentary yarn and at most 20 mass % of other components, wherein at least 50 mass
% of the yarn consists of colored gel-spun filaments obtained by spinning a mixture containing ultra-high molecular weight
polyethylene (UHMwPE) having an intrinsic viscosity (IV) of between about 8 and 40 dl/g, a spin solvent and a pigment, wherein
the colored filaments consists of UHMwPE, between 0.1 and 7.0 wt. % of an inorganic chromium oxide-containing pigment, a residual
amount of less than about 100 ppm of the spin solvent, and less than 1000 ppm of further constituents.
US Pat. No. 9,370,772

CATALYTIC SYSTEM

DSM IP ASSETS B.V., Heer...

1. A method for the partial hydrogenation of 6-hydroxy-3-(5-hydroxy-3-methyl-pent-3-in-1-ynyl)-2,4,4-trimethylcyclohex-2-enone
to 6-hydroxy-3-(5-hydroxy-3-methyl-penta-1,3-dienyl)-2,4,4-trimethylcyclohex-2-enone, the method comprising:
(a) subjecting 6-hydroxy-3-(5-hydroxy-3-methyl-pent-3-in-1-ynyl)-2,4,4-trimethylcyclohex-2-enone to conditions of at least
partial hydrogenation in the presence of a Lindlar-type catalyst which comprises, based on total weight of the catalyst:

(i) 85 wt. % to 99.85 wt. % of CaCO3 having an average particle size (d50) of 10 ?m to 120 ?m,

(ii) 0.1 wt. % to 10 wt. % of Pd, and
(iii) 0.05 wt. % to 5 wt. % of Pb; and
(b) obtaining 6-hydroxy-3-(5-hydroxy-3-methyl-penta-1,3-dienyl)-2,4,4-trimethylcyclohex-2-enone from the partial hydrogenation
conditions of step (a) at a selectivity of greater 90%.

US Pat. No. 9,345,656

ACRYLIC POLYMER

DSM IP ASSETS B.V., Heer...

1. A hair styling method which comprises applying to hair of a person in need of hair styling an effective amount of a hair
styling composition comprising an acrylic emulsion polymer which is the emulsion polymerized reaction product of a monomer
mixture consisting of 10-30 wt. % methacrylic acid, 5-15 wt. % ethyl acrylate and 60-80 wt. % n-butyl methacrylate, based
on 100 wt. % of the monomer mixture, wherein the acrylic emulsion polymer has a total residual monomer content below 500 ppm.
US Pat. No. 9,238,719

PROCESS FOR PRODUCING HIGH MOLECULAR WEIGHT POLYETHYLENE

DSM IP ASSETS B.V., Heer...

1. A process for producing an (ultra)high molecular weight polyethylene ((U)HMWPE) article comprising:
providing a (U)HMWPE resin composition comprising (U)HMWPE resin having a molecular weight distribution (Mw/Mn) of between
2 and 18, and a stabilizer consisting of at least one Hindered Amine Light Stabilizer (HALS); and

subjecting the (U)HMWPE resin composition during or after molding to a radiation dosage from 30 to 250 kGy sufficient to effect
cross-linking of the (U)HMWPE resin composition and obtain a (U)HMWPE article having a cross-link density of 0.09 mol/dm3 or more.

US Pat. No. 9,101,589

BEADLETS COMPRISING HOP ACID SALTS IN A STARCH MATRIX

DSM IP ASSETS B.V., Heer...

1. A process for preparing beadlets, which comprise at least one hop acid salt, comprising:
(a) forming an aqueous solution of:
(i) at least a hop acid salt, and
(ii) at least one starch and/or starch derivative,
(b) adjusting the pH of the solution to pH greater than 9, and
(c) converting the solution into a dry powder by spray drying into a starch collecting powder, wherein
the beadlets comprise at least 3 wt-%, based on the total weight of the beadlets, of the starch collecting powder as a coating
layer.

US Pat. No. 9,322,190

MODULAR MULTI-STORY PRODUCTION PLANT AND METHODS FOR CONSTRUCTING SAME

DSM IP ASSETS B.V., Heer...

1. A modular production plant comprising:
a vertical stack of production modules for supporting production equipment; and
a vertical stack of operator access modules adjacently connected to the vertically stacked production modules to allow operator
access to the production modules, wherein

the adjacently connected vertical stacks of production modules and operator access modules establish multiple stories of the
modular production plant, wherein

each of the production modules and operator access modules have a rectangular parallelepiped shape which is sized and configured
to fit within a standard 20-foot shipping container, and wherein

each of the operator access modules comprises a first portion having a stairwell comprised of a flight of stairs and a stair
landing, and a second portion comprising an elevator well adjacently positioned relative to the first portion, wherein

the vertical stack of operator access modules are positioned relative to one another so that the adjacent first and second
portions of each operator access module are vertically stacked with the first and second portions of a vertically adjacent
one of the operator access modules to thereby establish a vertically oriented stairwell and a vertically oriented elevator
well from one access module to another, wherein

the vertical stack of operator access modules includes an operator elevator positioned within the elevator well of the vertically
stacked second portions of the operator access modules, the operator elevator being capable of ascending/descending movement
within the elevator well from one of the multiple stories of the modular production plant to another.

US Pat. No. 9,242,789

PROCESS FOR FOIL RIPENING OF CHEESE

DSM IP ASSETS B.V., Heer...

1. A process for preparing foil-ripened cheese comprising (i) introducing cheese after brining into a cheese-aging packaging
containing an opening for receiving cheese, (ii) closing the packaging, and (iii) ripening the cheese, characterized in that
the cheese-aging packaging comprises a thermoplastic, monolithic film and the closed cheese-aging packaging has a water vapor
transmission rate of at least 10 g/m2/24 hours at 10° C. and 85% relative humidity and an oxygen permeability of at most 100 cm3/m2/24 hours/atm at 10° C. and 85% relative humidity.

US Pat. No. 9,162,969

NITROOXYESTERS, THEIR PREPARATION AND USE

DSM IP ASSETS B.V., Heer...

1. A nitrooxyester of formula I:

wherein n, m and p are independently from each other integers from 0 to 50, with the proviso that at least one of n, m and
p is not 0 and with the further proviso that n+p+m is at most 50;

X1 and X2 are independently from each other an oxo group or a hydrocarbon moiety which may contain (a) at least one C?C double bond,
(b) at least one oxy group and/or (c) at least one oxygen atom;

R1 and R2 are independently from each other hydrogen, hydroxy, alkoxy or O(CO)[ONO2]x with L being a straight alkylene having 2 to 25 carbon atoms, a branched alkylene having 3 to 25 carbon atoms, a cyclic alkylene
having 3 to 25 carbon atoms, an arylene having 6 to 16 carbon atoms or an alkylarylene having 7 to 16 carbon atoms and with
x being an integer 1 depending on chain length;

R3 and R4 are independently from each other hydrogen or in case of a triple bond both do not exist;

R5 and R6 are independently from each other hydrogen or C1-6 alkyl; and

with the proviso that the compound of formula I contains at least one O(CO)[ONO2]x group as defined above.

US Pat. No. 9,499,841

CELL SUITABLE FOR FERMENTATION OF A MIXED SUGAR COMPOSITION

DSM IP ASSETS B.V., Heer...

1. A transformed Saccharomyces cerevisiae cell suitable for producing at least one fermentation product from a sugar composition comprising glucose, galactose, xylose,
arabinose and mannose, wherein said cell comprises:
(a) two to fifteen copies of at least one xylose isomerase gene or two to fifteen copies of at least one xylose reductase
and xylitol dehydrogenase, and

(b) from two to ten copies of L-arabinose isomerase (araA), L-ribulokinase (araB), and L-ribulose-5-phosphate 4-epimerase (araD) genes,

wherein said genes are integrated into the cell genome,
and wherein said cell comprises a disruption or deletion of the GAL80 (transcriptional repressor) gene.
US Pat. No. 9,080,029

E/E CONNECTOR AND POLYMER COMPOSITION USED THEREIN

DSM IP ASSETS B.V., Heer...

1. An electrical connector for joining electrical circuits together in electrical or electronic applications, comprising a
conductive element and a plastic housing, wherein at least part of the conductive element is embedded in the housing, and
wherein the plastic housing comprises a flame retardant polyamide composition which exhibits blister resistance when heated
during a reflow soldering of the conductive element to a peak temperature in the range of 260° C. to 300° C., wherein the
flame retardant polyamide composition consists of:
25-80 wt. % of a semi-aromatic polyamide having a glass transition temperature (Tq) of at least 110° C. and at most 140° C.
and a melt temperature (Tm) of at least 300° C. and at most 340° C.;

5-50 wt. % of a reinforcing agent;
1-40 wt. % of a flame retardant system comprising at least one flame retardant; and
0-25 wt. % polymers other than the semi-aromatic polyamide,
0-25 wt. % inorganic fillers, and/or
0-5 wt. % auxiliary additives, wherein
the weight percentages (wt. %) are relative to the total weight of the composition and wherein the semi-aromatic polyamide
comprises units derived from aliphatic diamines and dicarboxylic acids, and wherein

a) the dicarboxylic acids (A) consist of a mixture of (A1) 5-65 mole % aliphatic dicarboxylic acid, less than 25 mole % aromatic
dicarboxylic acids other than terephthalic acid, and (A2) 35-95 mole % terephthalic acid;

b) the aliphatic diamines (B) consist a mixture of (B1) 10-70 mole % of a short chain aliphatic diamine with 2-5 C atoms,
and (B2) 30-90 mole % of a long chain aliphatic diamine with at least 6 C atoms; and

c) the combined molar amount of the terephthalic acid (A2) and the long chain aliphatic diamine (B2) is at least 60 mole %,
relative to the total molar amount of the dicarboxylic acids and diamines.

US Pat. No. 9,068,042

TRANSPARENT FILMS

DSM IP ASSETS B.V., Heer...

1. An optically transparent extrudate product made of a polymer composition comprising at least 60 wt. %, relative to total
weight of the polymer composition, of a semi-crystalline polyamide (A) having a melting temperature TmA of at least 270° C.,
wherein the semi-crystalline polyamide (A) is a semi-crystalline semi-aromatic polyamide or a blend thereof with a semi-crystalline
aliphatic polyamide, and wherein the polymer composition has a melting temperature TmC of at least 270° C., and the extrudate
product has a haze of less than 12% and a light transmittance of at least 88%, measured with the method according to ASTM
D1003A.

US Pat. No. 9,487,602

FURAN BASED RESIN, PROCESS FOR THE PREPARATION THEREOF, AND USE OF THE COMPOUND

DSM IP ASSETS B.V., Heer...

1. A polymeric reaction product having the following repeat unit of formula (V):

where:
R2 and R3 are independently H, OH substituted or unsubstituted C1-12alkyl, substituted or unsubstituted C1-12alkenyl, C1-12aldehyde, C3-12acetal, C2-12ether, or C2-12ester;

R7 and R10 are independently nil, —O—, substituted or unsubstituted C1-12alkyl, substituted or unsubstituted C1-12alkenyl, C1-12aldehyde, C3-12acetal, C2-12ether, or C2-12 ester;

X is H or C1-4alkyl; and

Z is an electron-withdrawing group.
US Pat. No. 9,458,096

PROCESS FOR THE MANUFACTURE OF METHYL LIMONITRILE

DSM IP ASSETS B.V., Heer...

1. A process for the manufacture of methyl limonitrile comprising a mixture of 3,7-dimethyl-2,6-nonadiene nitrile, 3,7-dimethyl-3,6-nonadiene
nitrile and 7-methyl-3-methylene-6-nonene nitrile, wherein the process comprises the following steps:
a) reacting 6-methyl-5-octen-2-one with cyano acetic acid and removing carbon dioxide and water, wherein the reaction of 6-methyl-5-octen-2-one
with cyano acetic acid and the removal of carbon dioxide and water are performed in the presence of a base and a co-base 1
in an organic solvent which forms a heteroazeotrop with water;

b) removing the organic solvent and the base of a mixture obtained after having performed step a) or step c) by distillation,
optionally in the presence of a co-base 2; and

c) isomerizing the mixture obtained after having performed step a) or step b) in the presence of a co-base 2 to obtain an
isomerized reaction mixture; wherein

step b) can be performed before or after step c), and wherein the co-base 2 is selected from the group consisting of 1,4-diaminobutane,
1,5-diaminopentane, piperidine and mixtures thereof.

US Pat. No. 9,382,646

ABRASION RESISTANT YARN

DSM IP ASSETS B.V., Heer...

1. A spun yarn comprising natural fibers and high strength polyethylene staple fibers, wherein
the high strength polyethylene staple fibers have an initial modulus of at least 40 GPa and a tensile strength of at least
1.4 GPa, and wherein

the yarn comprises between 1 and 4% by weight of the high strength polyethylene staple fibers, and wherein
the yarn is a homogenous mixture of the natural fibers and the high strength polyethylene fibers which does not exhibit a
gradient of the high strength polyethylene staple fibers across a cross-section of the yarn orthogonal to a machine direction
of the yarn such that a ratio of highest and lowest weight percentages of the high strength polyethylene staple fibers across
the cross-section of the yarn orthogonal to the machine direction of the yarn is at most 2.

US Pat. No. 9,228,096

RADIATION CURABLE COMPOSITION

DSM IP ASSETS B.V., Heer...

1. A radiation curable composition comprising:
(a) 15 to 85 wt % of at least one solvent comprising ?20 wt % of water;
(b) 5 to 50 wt % of at least one radiation curable material having a Mn in the range of from 50 to 10,000 g/mol and an average
acrylate functionality in the range of from 2 to 6;

(c) 10 to 70 wt % of at least one polyurethane having
(i) a Mw in the range of from 4,000 to 70,000 g/mol;
(ii) 0 to 1.5 wt % of isocyanate-reactive component(s) bearing ionic or potentially ionic water-dispersing groups; and
(iii) a free isocyanate group content <0.5 wt %;
wherein the at least one solvent (a) comprises ?74 wt. % solvents having an evaporation rate ?1.0 in relation to butyl acetate
having an evaporation rate of 1.0; and

wherein the composition has solids content of 25 to 85 wt. %; and
wherein (a), (b) and (c) add up to 100%; and
wherein the ratio of (b) to (c) is in the range of from 9/91 to 40/60.
US Pat. No. 9,167,822

ANTIFUNGAL COMPOSITIONS

DSM IP ASSETS B.V., Heer...

1. A composition comprising natamycin and at least one antifungal compound from the family of pyrazole fungicides selected
from the group consisting of bixafen and isopyrazam, wherein each of natamycin and at least one antifungal compound are present
in synergistically effective amounts.
US Pat. No. 9,109,107

PEROXIDE COMPOSITION

DSM IP ASSETS B.V., Heer...

1. A peroxide composition comprising
i) tertiarybutyl peroxy isopropyl carbonate; and
ii) a polyalkylene polyol selected from the group consisting of 1,2-polypropylene glycol and polyethylene glycol that acts
as a diluent for the organic monoperoxycarbonate, wherein

the polyalkylene polyol is an oligomer or polymer having a number average molecular weight as measured by gel permeation chromatography
from 400 up to and including 2000 g/mol, and wherein

the polyalkylene polyol is present in an amount of at least 23 and lower than 95 wt. % relative to total weight of the peroxide
composition.

US Pat. No. 9,101,151

HIGH-QUALITY LIPIDS PRODUCED BY ENZYMATIC LIBERATION FROM BIOMASS

DSM IP Assets B.V., Heer...

1. A refined, bleached, or deodorized microbial or plant lipid comprising polyunsaturated fatty acid, wherein said lipid has
an anisidine value of 1.5 or less, wherein said lipid has been liberated from biomass enzymatically and through addition of
a surfactant, and wherein said polyunsaturated fatty acid present in said lipid comprises at least 20 weight percent docosahexaenoic
acid, at least 5 weight percent docosapentaenoic acid, or at least 20 weight percent arachidonic acid.
US Pat. No. 9,452,061

SPINAL FUSION CAGE

DSM IP ASSETS B.V., Heer...

1. A spinal fusion cage for implantation between two adjacent vertebrae, the spinal fusion cage comprising at least first
and second polymeric materials present as layers, wherein a layer of the second polymeric material is embedded between two
layers of the first polymeric material, and the first and second polymeric materials are chemically or physically connected
to one another, and wherein the first polymeric material of the spinal fusion cage has a tensile modulus between 0.001 and
<1.0 GPa, and wherein the second polymeric material of the spinal fusion cage has a tensile modulus between 1.0 and 20 GPa,
and wherein the spinal fusion cage has a maximum compression that is higher than 0.05% of an original height of the spinal
fusion cage, wherein the maximum compression is defined as a difference in millimeters (mm) between original and compressed
heights of the spinal fusion cage at a load equal to a stress level of 2 MPA working on contact areas thereof wherein the
maximum compression does not change structural integrity of the cage.
US Pat. No. 9,434,671

NITROGEN MONOXIDE AS CIS/TRANS ISOMERIZATION CATALYSTS FOR UNSATURATED COMPOUNDS

DSM IP ASSETS B.V., Heer...

1. A process of a cis/trans isomerization of an unsaturated compound A having at least one but not more than two conjugated
carbon-carbon double bonds, the compound A being selected from the group consisting of unsaturated ketones, unsaturated ketals,
unsaturated aldehydes, unsaturated acetals, unsaturated carboxylic acids, esters of an unsaturated carboxylic acid, amides
of an unsaturated carboxylic acid and unsaturated alcohols, wherein the process comprises the steps of:
a) providing a cis or a trans isomer of the unsaturated compound A;
b) adding nitrogen monoxide to the cis or trans isomer of the unsaturated compound A of step a) to form a mixture thereof;
c) heating the mixture of nitrogen monoxide and cis or trans isomer of the unsaturated compound A to a temperature of between
10° C. and the boiling point of the unsaturated compound A, thereby leading to a mixture of cis/trans isomers of the unsaturated
compound A.

US Pat. No. 9,327,433

PROCESS FOR COMPACTING POLYMERIC POWDERS

DSM IP ASSETS B.V., Heer...

1. A process for compacting a polymeric powder in a press, wherein the process comprises supporting the polymeric powder during
compaction in the press by a powder carrier, wherein the powder carrier comprises a layer of a thickness (T), wherein the
layer comprises a material with a static coefficient of friction (COF), and wherein T×COF is at least 10 ?m.

US Pat. No. 9,248,431

STEPWISE HYDROGENATION OF SPECIFIC ISOPRENOIDS

DSM IP ASSETS B.V., Heer...

1. A stepwise heterogeneous catalytic hydrogenation process which comprises:
(1) a first step of hydrogenating a compound of formula (I)

wherein n=0, 1, 2, 3, 4 or 5,
to a compound of formula (II)

wherein n has the same meaning as in formula (I), and thereafter
(2) a second step of hydrogenating the compound of formula (II) to a compound of formula (III)

wherein n has the same meaning as in formula (I), wherein
(i) H2-gas is used for hydrogenation, and

(ii) hydrogenation is conducted in the presence of a structured catalyst coated by a non-acidic metal oxide layer impregnated
with Pd-nanoparticles, wherein the non-acidic metal oxide layer comprises MgO and optionally at least one further metal oxide,
and is substantially free from any Zn.

US Pat. No. 9,243,109

BI-AXIALLY STRETCHED PRODUCT

DSM IP ASSETS B.V., Heer...

1. A biaxially stretched product comprising a copolyamide comprising monomeric units of:
(i) aliphatic non-cyclic diamines X and aliphatic non-cyclic dicarboxylic acids Y or aliphatic non-cyclic ?,?-amino acids
Z, and

(ii) diamines M and diacids N in an amount between 0.1 to 1.5 wt % based on the total amount of copolyamide, and in which
M and N are cyclic, wherein

the product has been stretched at a temperature of between the glass transition temperature (Tg) and the melting temperature
(Tm).

US Pat. No. 9,242,218

PROCESS FOR HEAT TREATMENT OF SEMI-CRYSTALLINE POLYMERS

DSM IP ASSETS B.V., Heer...

1. A continuous heat treatment process for heat treatment of a particulate thermoplastic material comprising a thermoplastic
semi-crystalline polymer in a solid state, the process comprising:
(a) carrying out one or more heating steps in a flow-through installation comprising one or more heating zones, wherein each
heating zone comprises a contact heater consisting of an array of heating plates;

(b) feeding the particulate material to the flow-through installation;
(c) transporting the granulate material in the one or more zones as a non-fluidized moving packed bed in the absence of mechanical
agitation;

(d) discharging the particulate material from the flow-through installation;
(e) heating the particulate material by energy input coming at least 70% from the contact heater associated with each heating
zone; and optionally

(f) applying a flow of inert gas in one or more of the heating zones, wherein the flow of inert gas in the one or more heating
zones, if any, complies with a mass ratio G/M of at most 2, wherein G is inert gas flow in kg/hour and M is particulate material
flow in kg/hour.

US Pat. No. 9,243,267

COMPOSITIONS AND METHODS FOR MAKING AND MODIFYING OILS

DSM IP ASSETS B.V., Heer...

1. A method for generating one or more fatty acid species comprising
(a) providing an oil or a lipid comprising at least one species of fatty acid;
(b) providing a lipase that is at least 80% identical to the amino acid sequence as set forth in SEQ ID NO:1174, SEQ ID NO:1178,
SEQ ID NO:1180, SEQ ID NO:1182 or SEQ ID NO:1184; and

(c) contacting the oil or lipid of (a) with the enzyme of (b) under conditions wherein the enzyme selectively hydrolyzes at
least one fatty acid species molecule from the oil or lipid, thereby releasing the fatty acid species from the oil or lipid
and generating the fatty acid species.

US Pat. No. 9,163,341

MULTIFILAMENT YARN CONSTRUCTION

DSM IP ASSETS B.V., Heer...

1. A multifilament yarn construction comprising a core part and a sheath part, the core part comprising a plurality of core
filaments, and the sheath part comprising a plurality of sheath filaments, wherein
the sheath part is between 4 to 75 area-% of a cross section of the multifilament yarn construction,
the sheath part is braided onto the core part,
the braiding angle (?) of the sheath part is at least 30°,
the width of the multifilament yarn construction is between 0.2 to 5 mm, and
the flexural yield stress, ?5%, of the multifilament yarn construction is at least 3 N/mm2.

US Pat. No. 9,163,224

CARBOHYDRATE DEGRADING POLYPEPTIDE AND USES THEREOF

DSM IP ASSETS B.V., Heer...

1. A variant polypeptide having at least 96% sequence identity with the sequence set out in SEQ ID NO:2 or the mature form
thereof, wherein said variant polypeptide or mature form thereof has one or more substitutions or insertions relative to SEQ
ID NO:2, and wherein the polypeptide has beta-cellobiohydrolase activity.
US Pat. No. 9,155,317

ANTIFUNGAL COMPOSITIONS

DSM IP ASSETS B.V., Heer...

1. A composition comprising natamycin and at least one antifungal compound selected from the group consisting of cyprodinil
and pyrimethanil.
US Pat. No. 9,150,702

LASER-MARKING ADDITIVE

DSM IP ASSETS B.V., Heer...

1. A laser-marking additive comprising:
a functionalized carrier polymer, and
a bismuth-containing compound melt-blended with the functionalized carrier polymer, wherein
the bismuth-containing compound is at least one selected from the group consisting of Bi2O3 and Bi-citrate, and wherein

the functionalized carrier polymer comprises an amount of functional groups based on total weight of the functionalized polymer
and

the bismuth-containing compound of 0.01 to 50 wt % sufficient to achieve no discoloration of a thermoplastic matrix polymer
when the laser-marking additive is melt-blended with the thermoplastic matrix polymer at a temperature above 220° C., wherein

the laser-marking additive is antimony-free and halogen-free.
US Pat. No. 9,096,711

POWDER COATING COMPOSITION COMPRISING A POLYESTER AND A CROSSLINKER WITH OXIRANE GROUPS PROVIDING IMPROVED CORROSION RESISTANCE TO A SUBSTRATE COATED THEREWITH

DSM IP ASSETS B.V., Heer...

1. A carboxylic acid functional branched polyester for thermosetting powder coating composition, wherein
the carboxylic acid functional branched polyester is prepared from at least the following monomers: a difunctional aromatic
acid, the difunctional aromatic acid being a combination of terephthalic acid (TPA), isophthalic acid (IPA), an at least trifunctional
monomer and a difunctional alcohol, the difunctional alcohol being a combination of at least neopentyl glycol (NPG) with one
or both of ethylene glycol (EG) and diethylene glycol (DEG), and

a fatty acid salt in an amount from 0 to 0.59 mol % based on the carboxylic acid functional branched polyester, and
the molar ratio of TPA to IPA in the carboxylic acid functional branched polyester is higher than 5 and at most 12.4, and
the functionality of the carboxylic acid functional branched polyester is from 2.15 to 4.0, and
the carboxylic acid functional branched polyester has an acid value of from 14 to 80 mg KOH/g carboxylic acid functional branched
polyester, and

the carboxylic acid functional branched polyester has a hydroxyl value less than 10 mg KOH/g carboxylic acid functional branched
polyester; and

the carboxylic acid functional branched polyester has a glass transition temperature of at least 40° C. and a viscosity at
160° C. of at most 125 Pa·s.

US Pat. No. 9,062,083

D1479 STABLE LIQUID BAP PHOTOINITIATOR AND ITS USE IN RADIATION CURABLE COMPOSITIONS

DSM IP ASSETS B.V., Heer...

1. A stabilized liquid bis(acyl)phosphine of formula (I):

wherein each of Ar1, Ar2 and Ar3 is independently selected from the group consisting of a phenyl group, a methylphenyl group, an ethylphenyl group, a dimethylphenyl
group, a trialkylphenyl group, an isopropylphenyl group, a tert-butyl phenyl group, a methoxy phenyl group, a dimethoxyphenyl
group, an ethoxy phenyl group, a diethoxy phenyl group, an isopropoxy phenyl group, a thiomethoxy phenyl group, a naphthyl
group, a thiophenyl group and a pyridyl group; and

wherein said stabilized liquid bis(acyl)phosphine is liquid at 20° C. and is stabilized as a composition comprising less than
about 1.0 wt. % of water.

US Pat. No. 9,596,878

USE OF CANTHAXANTHIN

DSM IP ASSETS B.V., Heer...

3. A process for reducing the rate of internal egg quality degradation as expressed in terms of Haugh units which comprises
feeding a laying poultry hen a diet which contains from about 2 ppm to 100 ppm of canthaxanthin and about 10 ?g/kg to about
100 ?g/kg of 25-hydroxy vitamin D3 sufficient such that the rate in decrease in Haugh unit value of the eggs from said hen
is significantly reduced as compared to the rate of such decrease under the same conditions with the same diet absent the
canthaxanthin and the 25-hydroxy vitamin D3.
US Pat. No. 9,516,893

USE OF TRYPTOPHAN RICH PROTEIN HYDROLYSATES

DSM IP ASSETS B.V., Heer...

1. An edible composition which imparts a feeling in a healthy adult consumer which is selected from the group consisting of:
a) increased energy;
b) an increase in certain cognitive functions including, sustained attention, faster reaction times, and information processing;
c) increased quality of sleep; or
d) increased feelings of well-being or happiness, wherein the composition is a pharmaceutical, food or food supplement comprising
a hen egg lysozyme tryptophan-containing hydrolysate (Trp-containing protein hydrolysate) having a ratio (Trp/LNAA) of tryptophan
(Trp) to large neutral amino acid (LNAA) of greater than 0.15, and wherein the dosage of the Trp-containing protein hydrolysate
provides 10-100 mg of Trp per day.

US Pat. No. 9,453,172

BIOLOGICAL OILS AND PRODUCTION AND USES THEREOF

DSM IP Assets B.V., Heer...

1. A method for producing a biological oil comprising at least two steps:
(a) growing an oil-forming microorganism of the genus Schizochytrium, by heterotrophic fermentation in a fermentor that has not been sterilized, wherein the fermentation comprises two stages:
(i) a first stage that targets accumulation of a biomass of the microorganism and (ii) a second stage that targets lipid accumulation
by the microorganism and wherein 11% to 99% of the unsaturated fatty acids in said biological oil are polyunsaturated fatty
acids; and

(b) isolating or purifying the biological oil made in step (a), wherein the isolating comprises extraction of the oil from
the biomass.

US Pat. No. 9,445,979

HAIR TREATMENT COMPOSITION CONTAINING GAMBOGIC ACID, ESTER OR AMIDE

DSM IP ASSETS B.V., Heer...

1. Method for enhancing and/or to restoring hair growth, said method comprising the step of applying to skin having hair of
a human in need of enhancing or restoring hair growth a topical composition comprising an effective amount of a compound of
formula (I) or formula (II):

wherein R1 and R2 are both independently hydrogen (H), or a saturated, straight or branched C1-C8 alkyl group.

US Pat. No. 9,415,374

DEVICE USEFUL FOR HYDROGENATION REACTIONS (III)

DSM IP ASSETS B.V., Heer...

1. A device for treatment of material transported through the device comprising at least one porous element which allows cross-flow
of the material through the device, wherein
the at least one porous element consists of a solid metallic structure which is coated by a non-acidic metal oxide layer impregnated
with Pd-nanoparticles having an average particle size of between 0.5 and 20 nm, and wherein

the at least one porous element is formed of a metal alloy comprising:
(i) 55 wt-%—80 wt-%, based on total weight of the metal alloy, of Co,
(ii) 20 wt-%—40 wt-%, based on total weight of the metal alloy, of Cr, and
(iii) 2 wt-%—10 wt-%, based on total weight of the metal alloy, of Mo.
US Pat. No. 9,408,404

METHOD FOR PRODUCING LIPIDS BY LIBERATION FROM BIOMASS

DSM IP Assets B.V., TE H...

1. A method for obtaining a polyunsaturated fatty acid-containing lipid from a biomass, comprising:
a) contacting an enzyme and a surfactant with a biomass at a temperature of about 10 degree Celsius to about 80 degree Celsius,
and at a pH level of about pH 5 to about pH 9, said enzyme degrading a portion of the biomass impeding recovery of the lipid,
and the portion of the biomass is selected from the group consisting of proteins, polysaccharides, cell wall, outer cell membrane,
peptidoglycan layer, lipid bilayer, cellulose, chitin, hemicellulose, lignin, and lignin-related compounds,

b) recovering said lipid having an anisidine value of 0.8 comprising at least 20 weight percent docosahexaenoic acid, at least
5 weight percent docosapentaenoic acid, and/or at least 20 weight percent arachidonic acid; and

c) treating the recovered lipid by refining, bleaching, or deodorizing.

US Pat. No. 9,322,045

HOST CELL FOR THE PRODUCTION OF A COMPOUND OF INTEREST

DSM IP ASSETS B.V., Heer...

1. A recombinant host cell for the production of a compound of interest, said recombinant host cell comprising at least two
substantially homologous DNA domains comprising flanking regions of at least 100 base pairs and overall homology of the flanking
regions of at least 60%, wherein said at least two substantially homologous DNA domains are suitable for integration of one
or more copies of a polynucleotide of interest wherein at least one of the at least two substantially homologous DNA domains
is adapted to have enhanced integration preference for the polynucleotide of interest compared to the substantially homologous
DNA domain it originates from, and wherein the substantially homologous DNA domain where the adapted substantially homologous
DNA domain originates from has a gene conversion frequency that is at least 10% higher than one of the other of the at least
two substantially homologous DNA domains, and wherein the recombinant host cell is deficient in glaA and at least one component
selected from the group consisting of amyA, amyBI, amyBII, oahA, a toxin associated polynucleotide, and a fungal transcriptional
activator of protease (prtT) as compared to a parent cell that the recombinant host cell originates from when cultivated under
comparable conditions.

US Pat. No. 9,315,625

MELT-PROCESSABLE POLYAMIDE WITH HIGH MELTING TEMPERATURE

DSM IP ASSETS B.V., Heer...

1. A polyamide comprising units derived from:
(A) a diamine comprising in its structure at least one cyclohexane fragment according to Structure I, in which the substituents
are in the 1,4-trans-position,


 wherein n is a positive integer of at least 1, with the proviso that when n is 2 or higher the cyclohexane rings are connected
to each other through the 1,4-trans position, and

(B) an aliphatic dicarboxylic acid selected from the group consisting of 18 octadecanedioc acid, 1, 19-nonadecanedioic acid
and fatty acids having between 13 and 22 carbon atoms, wherein

1) the units derived from the diamine (A) make up more than 40 mol % based on the total amount of diamines, and wherein
2) the units derived from the dicarboxylic acid (B) make up at least 70 mol % of the total of dicarboxylic acids.
US Pat. No. 9,222,112

EICOSAPENTAENOIC ACID-PRODUCING MICROORGANISMS, FATTY ACID COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF

DSM IP Assets B.V., Heer...

1. A microbial oil comprising omega-3 polyunsaturated fatty acids comprising docosahexaenoic acid and eicosapentaenoic acid
in an amount of about ?90%, by weight, of the total amount of omega-3 polyunsaturated fatty acids, wherein the amount of eicosapentaenoic
acid, by weight, is from about 19% to about 55% of the total amount of docosahexaenoic acid and eicosapentaenoic acid, and
the amount of docosahexaenoic acid, by weight, is from about 35% to about 71% of the total amount of docosahexaenoic acid
and eicosapentaenoic acid, wherein the total amount of omega-3 polyunsaturated fatty acids is at least about 400 mg per one
gram of oil.
US Pat. No. 9,220,689

NANOPARTICLES

DSM IP ASSETS B.V., Heer...

1. A method for the preparation of polymer-templated core-shell nanoparticles comprising the steps of:
(a) preparing a cationic polymeric core material comprising polymeric micelles employing a quaternized polymer; and
(b) coating said core material with a shell comprising silica by depositing the shell onto the polymeric micelles from at
least one silica precursor at a pH of between 6.2 and 9.0 to form the core-shell nanoparticles.

US Pat. No. 9,203,130

RF FILTER HOUSING

DSM IP ASSETS B.V., Heer...

1. A radio frequency (RF) filter housing for outdoor use, wherein
the RF filter housing is formed of a polymer composition comprised of (a) polyethylene terephthalate and (b) glass fibres,
and wherein

the polymer composition forming the RF filter housing is plated with an electrically conductive layer comprising a top layer
of silver (Ag) to provide shielding of electro-magnetic interferences (EMI) of electronic components within the housing, and
wherein

the RF filter housing exhibits no blistering or peeling of the silver (Ag) layer from the polymer composition forming the
RF filter housing when subjected to an atmosphere of 85° C. and 85% relative humidity for 640 hours.

US Pat. No. 9,109,213

POLYPEPTIDE HAVING CARBOHYDRATE DEGRADING ACTIVITY AND USES THEREOF

DSM IP ASSETS B.V., Heer...

1. A variant polypeptide having at least 95% sequence identity with the sequence set out in SEQ ID NO: 2 or the mature form
thereof, wherein said variant polypeptide or mature form thereof has one or more substitutions or insertions relative to SEQ
ID NO: 2 and wherein said variant polypeptide has carbohydrate degrading activity.
US Pat. No. 9,090,750

PLASTIC COMPONENT FOR A LIGHTING SYSTEMS

DSM IP ASSETS B.V., Heer...

1. A polymer composition comprising 100 pbw of a semi-aromatic polyamide (X) and 1-250 pbw of an inorganic material, the semi-aromatic
polyamide X comprising repeat units derived from (A) dicarboxylic acids and (B) aliphatic diamines, wherein:
(a) the dicarboxylic acids (A) consist of (A1) a mixture of 5-65 mole % aliphatic dicarboxylic acid and optionally aromatic
dicarboxylic acid other than terephthalic acid, and (A2) 35-95 mole % terephthalic acid;

(b) the aliphatic diamines (B) consist a mixture of (B1) 10-70 mole % of a short chain aliphatic diamine with 2-5 C atoms
and (B2) 30-90 mole % of a long chain aliphatic diamine with at least 6 C atoms, wherein 50-100 mole % of the long chain diamine
(B2) consists of a diamine having 6 to 9 carbon atoms; and

(c) the combined molar amount of the terephthalic acid (A2) and the long chain aliphatic diamine (B2) is at least 60 mole
%, relative to the total molar amount of the dicarboxylic acids and diamines.

US Pat. No. 9,067,877

PROCESS FOR THE PRODUCTION OF 1,3,3-TRIMETHYL-2-(3-METHYLPENT-2-EN-4-YNYL)CYCLOHEX-1-ENE

DSM IP ASSETS B.V., Heer...

1. A process of production of 1,3,3-trimethyl-2-(3-methylpent-2-en-4-ynyl)cyclohex-1-ene according to formula (I):
wherein the process comprises dehydrating 3 methyl-5-(2,6,6-trimethylcyclohex-1-enyl)pent-1-yn-3-ol according to formula (II):

in the presence of at least one thiolate-bridged diruthenium complex as catalyst.

US Pat. No. 9,062,082

D1479 STABLE LIQUID BAP PHOTOINITIATOR AND ITS USE IN RADIATION CURABLE COMPOSITIONS

DSM IP ASSETS B.V., Het ...

1. A radiation curable composition for optical fiber comprising a liquid bis(acyl)phosphine of formula (I):

and at least one free-radical polymerizable component;
wherein each of Ar1, Ar2 and Ar3 is independently selected from the group consisting of a phenyl group, a methylphenyl group, an ethylphenyl group, a dimethylphenyl
group, a trialkylphenyl group, an isopropylphenyl group, a tert-butyl phenyl group, a methoxy phenyl group, a dimethoxyphenyl
group, an ethoxy phenyl group, a diethoxy phenyl group, an isopropoxy phenyl group, a thiomethoxy phenyl group, a naphthyl
group, a thiophenyl group and a pyridyl group; and

wherein said liquid bis(acyl)phosphine of formula (I) is liquid at 20° C. and is stabilized as a composition comprising less
than about 1.0 wt. % water.

US Pat. No. 9,056,829

PROCESS FOR THE ALKOXYCARBONYLATION OF FUNCTIONALIZED ALKENES

DSM IP ASSETS B.V., Heer...

1. A process for alkoxycarbonylation of carboxylic acid functionalized alkenes and/or esters thereof, said process comprising:
(a) reacting (i) a carboxylic acid functionalized alkene and/or ester thereof; (ii) a catalyst system comprising a source
of Pd and a ligand, (iii) an acid with a pKa<3, (iv) carbon monoxide, and (v) a hydroxyl group comprising compound, under
conditions wherein an ester carbonylation product is produced, whereby the process is carried out in initial presence of the
ester carbonylation product.
US Pat. No. 9,855,219

CORE-SHELL NANOPARTICLES

DSM IP ASSETS B.V., Heer...

13. A process for forming an anti-reflective coating on a substrate, the process comprising:
(i) forming core-shell nanoparticles having an average size of 10-200 nm by depositing a shell material comprising silica
onto a core material which is thermo-labile at a temperature of 150° C. to 600° C. and comprises a cationic vinyl copolymer
composition comprised of a polymer selected from the group consisting of poly(meth)acrylate and copolymers thereof having
cationic groups incorporated thereinto during polymerization;

(ii) forming a coating composition comprising the core-shell nanoparticles;
(iii) applying the coating composition to a substrate to thereby obtain an applied coating;
(iv) curing the applied coating; and
(v) subjecting the applied coating to an elevated temperature of at least 150° C. sufficient to remove some or all of the
core material from the core-shell nanoparticles in the applied coating.

US Pat. No. 9,541,351

MATERIAL SHEET AND PROCESS FOR ITS PREPARATION

DSM IP ASSETS B.V., Heer...

1. An integral material sheet with interconnected fibers comprising at least two integral monolayers, wherein
at least one integral monolayer of the integral material sheet is free of bonding agent and has a thickness of less than 100
?m, and wherein

the at least one integral monolayer comprises a plurality of drawn unidirectional polymer fibers having a strength of greater
than 1.2 GPa, and wherein

at least 80 wt. % of adjacent fibers within the at least one monolayer are mechanically fused together along at least 30%
of fiber length through mechanical interlocking thereby forming an integral material sheet with interconnected fibers, and
wherein

the fibers are monofilaments or filaments spread from a multifilament yarn, and wherein
the at least one monolayer has a maximum thickness of no more than 3 times a thickness of an individual fiber.

US Pat. No. 9,440,935

PROCESS FOR PRODUCING 2-PHENYL-1,3-BENZOXAZOLES

DSM IP ASSETS B.V., Heer...

1. Process for producing 2-phenyl-1,3-benzoxazoles of formula (I),

wherein
R1 is hydrogen, C1-C6-alkyl, halogen, OH or OR2; and

R2 is C1-C6-alkyl, propargyl or allyl,

said process comprising the steps of
(i) reacting 2-aminophenol (II) with a benzoyl chloride of formula (III) to the amide of formula (IV)

10 followed by

(ii) cyclisation of the amide (IV) to 2-phenyl-1,3-benzoxazol of formula (I),
wherein step (i) is carried out in an inert organic solvent in the presence of at least 0.75 mole-equivalent of sodium hydrogen
carbonate or potassium hydrogen carbonate based on the benzoyl chloride of formula (III).

US Pat. No. 9,397,392

GEODESIC RADOME

DSM IP ASSETS B.V., Heer...

1. A geodesic radome comprising shaped panels containing a consolidated plurality of plies, the plies comprising polyolefin
tapes, wherein the shaped panels have a compressive strength of between 10 MPa and 100 MPa, an interlaminar shear strength
of between 3 MPa and 75 MPa and a thermal expansion of between 1 e-6 1/K and 50e-6 1/K.
US Pat. No. 9,346,730

PROCESS FOR THE PRODUCTION OF FURFURAL AND LEVULINIC ACID FROM LIGNOCELLULOSIC BIOMASS

DSM IP ASSETS B.V., Heer...

1. A process for producing furfural and levulinic acid from lignocellulose-comprising biomass, said process comprising:
(a) adding water and optionally an acid to said biomass to form a slurried biomass;
(b) subjecting said slurried biomass to hydrolysis to form a hydrolysate comprising C5 and C6 sugars and further comprising
(insoluble) cellulose and lignin;

(c) subjecting said hydrolysate comprising said C5 and C6 sugars and said (insoluble) cellulose and lignin to solid/liquid
separation to yield a first aqueous fraction comprising at least part of said C5 and C6 sugars and a first solid fraction
comprising at least part of said cellulose and lignin;

(d) optionally concentrating said first aqueous fraction;
(e) adding an organic solvent to the optionally concentrated first aqueous fraction to form a biphasic system;
(f) heating said biphasic system to a temperature within the range of from 120 to 220° C. and maintaining said biphasic system
at that temperature range for a time sufficient to form furfural;

(g) cooling the biphasic system comprising furfural obtained in step (f);
(h) optionally subjecting the cooled biphasic system obtained in step (g) to solid/liquid separation and recovering the biphasic
system;

(i) subjecting the cooled biphasic system obtained in step (g) or the recovered biphasic system obtained in step (h) to a
separation step to yield an organic phase comprising at least part of said furfural and an aqueous phase comprising at least
part of said C6 sugars and optionally further comprising furfural;

(j) optionally recovering furfural from said organic phase;
(k) optionally using the recovered organic phase obtained in step (j) to extract furfural from the aqueous phase obtained
in step (i) by adding said recovered organic phase to said aqueous phase and repeating step (i) and optionally step (j);

(l) adding water and optionally an acid to the first solid fraction obtained in step (c) to form a suspension;
(m) subjecting the suspension obtained in step (l) to a temperature of between 140 and 220° C. to form levulinic acid;
(n) subjecting the suspension comprising levulinic acid obtained in step (m) to solid/liquid separation to yield a second
aqueous fraction comprising levulinic acid and a solid fraction; and

(o) optionally recovering said levulinic acid from the second aqueous fraction.
US Pat. No. 9,321,888

BRANCHED POLYAMIDE

DSM IP ASSETS B.V., Heer...

1. A branched polyamide prepolymer comprising repeat units derived from a monomer mixture comprising:
(A) a first monomer (referred to as monomer A) which is a linear or branched aliphatic diamine having two amino functional
groups, and

(B) a second monomer (referred to as monomer B) having two carboxylic acid functional groups which is at least one selected
from the group consisting of adipic acid, terephthalic acid, isophthalic acid and ester or acid chloride derivatives thereof,

and/or a salt of monomers A and B, and
(C) a third monomer (referred to as monomer C) which is at least one tris-amino functional compound selected from the group
consisting of bis(hexamethyene)triamine (BHT), diethylenetriamine (DETA) and tris(aminoethyl)amine (TAEA), wherein

the repeat units are present in molar amounts according to formula I and formula II:
Q=(MC*FC)/(MA+MB)  (Formula I) and

R=((MA*2)+(MC*FCA))/((MB*2)+(MC*FCB))  (Formula II)

wherein
MA, MB and MC represent the molar amounts of repeat units derived from the monomers A, B and C, respectively;
FC represent the functionality of monomer C, and is equal to FC-A+FC-B;
FC-A is the number of the amino functional groups comprised by monomer C;
FC-B is the number of carboxyl functional groups or precursor groups thereof comprised by monomer C;
Q is a number in the range of 0.06-1.00; and
R is a number in the range of 0.7-1.3, and wherein
the polyamide prepolymer has a viscosity number (VN), measured according to ISO 307, in the range of 7-30 mL/g.

US Pat. No. 9,249,074

SYNTHESIS OF TETRAHYDROMYRCENOL

DSM IP ASSETS B.V., Heer...

1. A process for production of compound of formula (I)
by a reductive ring-opening of a compound of formula (II)

US Pat. No. 9,206,301

RESIN COMPOSITION SUITABLE FOR (RE)LINING OF TUBES, TANKS AND VESSELS

DSM IP ASSETS B.V., Heer...

1. A structural, radically curable resin composition suitable for (re)lining comprising:
(a) 30-70 wt.% of resin having (i) a molecular weight Mn between 500 and 3000 and (ii) an acid value between 0 and 30 mg KOH/g
resin, and wherein at least 80% of the total amount of resin is vinyl ester resin,

(b) 30-70 wt.% of at least one reactive diluent, wherein at least 25% of the reactive diluent is a difunctional diluent having
a molecular weight Mn between 200 and 500 and an optional monofunctional diluent having a molecular weight Mn between 100
and 200,

(c) 0.00001 -5 wt.% of an initiator, and
(d) 0.00001-5 wt.% of an inhibitor, wherein
the average molecular weight per reactive unsaturation (WPU) of the components (a) and (b) is equal to or greater than 190
Dalton and that the amount of styrene in the resin composition is less than 5 wt.% based on the total weight of the components
(a), (b), (c) and (d), and wherein

the resin composition further comprises a monomaleate and/or monofumarate compound.
US Pat. No. 9,192,175

PROCESS FOR FOIL RIPENING OF CHEESE

DSM IP ASSETS B.V., Heer...

1. Process for preparing foil-ripened cheese comprising (i) introducing brined cheese into a cheese-ripening packaging containing
an opening for receiving cheese, (ii) closing the packaging and (iii) ripening the cheese, wherein the cheese-ripening packaging
comprises a thermoplastic film coated with an antimicrobial composition; the antimicrobial composition comprising a binding
agent and at least one antimicrobial compound, wherein (a) said binding agent swells, softens or dissolves in water that is
released from the cheese during its ripening, (b) the antimicrobial composition becomes part of water phase that, due to ripening,
becomes present between the outer cheese surface and the packaging, (c) the antimicrobial compound is able to migrate in the
water phase and (d) antimicrobial compound is transferred to the outer cheese surface, and wherein the thermoplastic film
has a water vapor transmission rate of at least 10 g/m2/24 hours at 10° C. and 85% relative humidity.
US Pat. No. 9,151,576

BALLISTIC RESISTANT ARTICLE

DSM IP ASSETS B.V., Heer...

1. An armor having a total areal density AD and a total energy absorption value Eabs, wherein the armor comprises in front
to back order:
at least one rigid first panel comprising inorganic fibers having a first areal density AD1ST and an energy absorption value Eabs1ST, and

at least one second panel comprising polymeric fibers having a second areal density AD2ND and an energy absorption value Eabs2ND, wherein

the areal density AD1ST of the at least one rigid first panel is at least 40% of the total areal density AD of the armor, and the areal density AD2ND of the at least one second panel is at most 60% of the total areal density AD of the armor, and wherein

the total energy absorption value Eabs exhibited by the armor is larger than a combination of the energy absorption value
Eabs1ST of the at least one rigid first panel and the energy absorption value Eabs2ND of the at least one second panel.

US Pat. No. 9,107,443

LIQUID NISIN COMPOSITIONS

DSM IP ASSETS B.V., Heer...

1. A method for preparing a liquid nisin composition, comprising the steps of:
a) mixing powder nisin with an aqueous solution to prepare a first liquid nisin containing composition having a pH of 3.5
to 12 and a final inorganic salt concentration of 1.5 M or below,

b) isolating solid compounds from the prepared first liquid nisin containing composition by centrifugation, filtration or
any combination thereof,

c) contacting the isolated solid compounds with a solution having a pH of 1 to 3 to prepare a second liquid nisin composition,
and optionally

d) removing solid compounds from the second liquid nisin composition.
US Pat. No. 9,096,675

CELL SUITABLE FOR FERMENTATION OF A MIXED SUGAR COMPOSITION

DSM IP ASSETS B.V., Heer...

1. A transformed Saccharomyces cerevisiae cell suitable for producing ethanol from a sugar composition comprising glucose, galactose, xylose, arabinose and mannose
wherein said cell comprises about eight copies of at least one xylose isomerase gene, and from two to four copies of L-arabinose isomerase (araA), L-ribulokinase (araB), and L-ribulose-5-phosphate 4-epimerase (araD) genes, wherein said genes are heteroloqous and are integrated into the cell genome.

US Pat. No. 9,086,527

SILICONE-CONTAINING MONOMER

DSM IP ASSETS B.V., Heer...

1. A silicone-containing monomer of formula (I);

wherein said silicone-containing monomer comprises a silicone-containing moiety and an oxazolidinone moiety and wherein R
is a silicone-containing moiety, and R1 is a moiety selected from the group consisting of


wherein A represents the oxazolidinone ring of the oxazolidinone moiety and R2 is a divalent C1-25 alkylene or a C6-30 arylalkylene.

US Pat. No. 10,072,179

VINYL FUNCTIONALIZED URETHANE RESINS FOR POWDER COATING COMPOSITIONS

DSM IP ASSETS B.V., Heer...

1. A vinyl functionalized urethane resin (VFUR) whereinthe VFUR is crystalline having a melting enthalpy measured via Differential Scanning calorimetry, of at least 35 J/g; and
the VFUR has a ratio (RVFUR) of urethane bonds in the VFUR to vinyl groups in the VFUR as measured by 1H-NMR spectroscopy of at least 1.04 and at most 1.80.
US Pat. No. 9,499,844

COMPOSITIONS AND METHODS FOR MAKING AND MODIFYING OILS

DSM IP ASSETS B.V., Heer...

1. A method for generating one or more fatty acid species comprising
(a) providing an oil or a lipid comprising at least one species of fatty acid;
(b) providing a lipase consisting of the amino acid sequence as set forth in SEQ ID NO:1160, SEQ ID NO:1166, SEQ ID NO:1170,
SEQ ID NO:1172 or SEQ ID NO:1176; and

(c) contacting the oil or lipid of (a) with the enzyme of (b) under conditions wherein the enzyme selectively hydrolyzes at
least one fatty acid species molecule from the oil or lipid, thereby releasing the fatty acid species from the oil or lipid
and generating the fatty acid species.

US Pat. No. 9,445,621

JUICE OR NECTAR FORMULATIONS

DSM IP ASSETS B.V., Heer...

1. A juice or nectar formulation comprising:
(i) juice or nectar,
(ii) an amount between 100 ppm-1000 ppm of at least one long chain polyunsaturated fatty acid (LC-PUFA) having a chain length
of 20 or more carbon atoms, and

(iii) an effective amount of 0.01 ppm-20 ppm of ?-carotene to suppress detectable fish taste in the formulation attributable
to the amount of the LC-PUFA in the formulation after storage for at least one month at 25° C.

US Pat. No. 9,403,929

PROCESS FOR PREPARING ACRYLIC POLYMER BEADS

DSM IP ASSETS B.V., Heer...

1. A process for the preparation of acrylic polymers beads, said process comprising the sequential steps of:
(i) subjecting a monomer composition consisting of a mixture of methacrylic acid (MAA), n-butyl methacrylate (BMA), ethylacrylate
(EA) and ethyl methacrylate (EMA) to suspension polymerization to form acrylic polymer beads, followed by

(ii) isolating the acrylic polymer beads obtained in step (i), followed by
(iii) washing the isolated acrylic polymer beads with purified water, wherein the purified water contains less than 1 mg/kg
of each of the following ions: Na+, K+, NH4+, Ca2+ and Mg2+.

US Pat. No. 9,387,281

PENDANT HYDROPHILE BEARING BIODEGRADABLE COMPOSITIONS AND RELATED DEVICES

DSM IP ASSETS B.V., TE H...

1. A composition comprising at least one polymer having the structure A-B-A?, wherein A and A? may be the same or different
and each is a degradable aliphatic polyester component and wherein B is the reaction product resulting from the reaction between
(i) A and A? and (ii) a diol, having one or more pendant oligomeric or polymeric groups, wherein B includes a pendant oligomeric
or polymeric oxyalkylene moiety.
US Pat. No. 9,334,488

XYLOSE ISOMERASE GENES AND THEIR USE IN FERMENTATION OF PENTOSE SUGARS

DSM IP ASSETS B.V., Heer...

1. A yeast cell comprising a nucleic acid construct comprising a heterologous nucleic acid with a nucleotide sequence encoding
a polypeptide that has xylose isomerase enzymatic activity, the expression of which polypeptide confers on, or increases in,
the yeast cell the ability to directly isomerize xylose into xylulose, wherein the amino acid sequence of the polypeptide
is at least 98% identical to SEQ ID NO:2 and comprises one or more conservative amino acid substitutions; wherein the one
or more conservative amino acid substitutions is selected from the group consisting of valine to leucine or isoleucine, phenyalanine
to tyrosine, lysine to arginine, alanine to valine, and asparagine to glutamine.
US Pat. No. 9,248,106

BEADLETS COMPRISING HOP ACID SALTS IN A PROTEIN MATRIX

DSM IP ASSETS B.V., Heer...

1. Process for preparing beadlets, which comprise at least one hop acid salt, comprising:
(a) forming an aqueous solution of
(i) at least a hop acid salt and
(ii) at least one protein or protein mixture,
(b) adjusting the pH of the solution to pH greater than 9
(c) converting the solution into a dry powder by spray drying into a collecting powder.
US Pat. No. 9,238,804

HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM

DSM IP ASSETS B.V., Heer...

1. A method for making an enzyme having altered substrate specificity or substrate preference comprising:
(a) providing a parental hydrolase of SEQ ID NO:2; and
(b) making from one to twelve amino acid residue modifications to the parental hydrolase, wherein at least one of the amino
acid residue modifications is V163R, thereby generating an enzyme having at least 95% sequence identity to SEQ ID NO:2 and
altered substrate specificity or substrate preference.

US Pat. No. 9,193,962

HYDROLASES, NUCLEIC ACIDS ENCODING THEM AND METHODS FOR MAKING AND USING THEM

DSM IP ASSETS B.V., Heer...

1. A cDNA comprising a nucleic acid sequence having at least 95% sequence identity to SEQ ID NO:923 over a region of at least
about 100 residues, wherein the nucleic acid encodes at least one polypeptide having a lipase activity, and the sequence identities
are determined by analysis with a sequence comparison algorithm or by a visual inspection.
US Pat. No. 9,109,214

HOST CELL CAPABLE OF PRODUCING ENZYMES USEFUL FOR DEGRADATION OF LIGNOCELLULOSIC MATERIAL

DSM IP ASSETS B.V., Heer...

1. A transformed host cell comprising at least four different heterologous polynucleotides encoding at least four different
Talaromvces enzymes selected from the group consisting of cellulases, hemicellulases and pectinases, wherein said transformed host cell
is a filamentous fungus and is capable of secreting said at least four different Talaromyces enzymes.
US Pat. No. 9,096,756

PROCESS FOR OBTAINING LOW FREE MONOMER LEVELS IN A BLOCK COPOLYMER EMULSION PREPARED WITH (REVERSE) IODINE TRANSFER POLYMERISATION

DSM IP ASSETS B.V., Heer...

1. A process for obtaining an aqueous emulsion comprising a block copolymer, which process comprises the following steps:
I) solution polymerisation of vinyl monomers to obtain block [B] in the presence of
a) a radical precursor; and
b) an iodine atom containing block [A];
to obtain a block copolymer comprising at least block [A] and a different block [B];
where block [A] and [B] together comprise 0 to 2 wt % of methacrylic acid;
where block [A] comprises 0 to 25 wt % of vinyl monomers bearing ionic or potentially ionic water-dispersing groups not including
methacrylic acid;

where block [B] comprises 0 to 25 wt % of vinyl monomers bearing ionic or potentially ionic water-dispersing groups not including
methacrylic acid;

where block [A] and block [B] together comprise >2.5 wt % of vinyl monomers bearing ionic or potentially ionic water-dispersing
groups not including methacrylic acid;

II) emulsification of the block copolymer obtained in step I);
III) performing a post polymerisation reaction on the block copolymer emulsion obtained in step II; and
wherein said aqueous emulsion has a free vinyl monomer level <1000 ppm when having a solids content of >20 wt %.
US Pat. No. 9,090,920

GENE SMS 27

DSM IP ASSETS B.V., Te H...

1. A microorganism selected from Gluconobacter oxydans wherein a gene encoding a polypeptide with the activity of a repressor of L-sorbosone dehydrogenase (SNDH) and L-sorbose dehydrogenase
(SDH) is disrupted, said gene comprising a polynucleotide selected from the group consisting of:
(a) polynucleotides encoding a polypeptide comprising the amino acid sequence of which is represented by SEQ ID NO:2;
(b) polynucleotide comprising the nucleotide sequence according to SEQ ID NO:1;
(c) polynucleotide the complementary strand of which hybridizes under highly stringent conditions to a polynucleotide as defined
in (a) or (b) and which encodes a polypeptide with the activity of a repressor of SNDH and SDH, wherein said highly stringent
conditions comprise hybridization at 42° C. for 2 to 4 days followed by one or more washes in 2×SSC, 0.1% SDS at room temperature
and one or more washes in 0.5×SSC, 0.1% SDS or 0.1×SSC, 0.1% SDS at 65 to 68° C.;

wherein said microorganism produces at least 10% more Vitamin C and/or 2-KGA from L-sorbose compared to the respective microorganism
wherein said repressor is intact.

US Pat. No. 10,062,962

COMPOSITE ANTIBALLISTIC RADOME WALLS AND METHODS OF MAKING THE SAME

DSM IP ASSETS B.V., Heer...

1. A composite radome wall structure comprising an antiballistic solid, void-free internal core and antireflective (AR) external surface layers which sandwich the core, wherein the antireflective external surface layers include a layer of material which comprise subwavelength surface (SWS) structures, wherein the SWS structures comprise surface relief gratings with a size smaller than a wavelength of incident radiation.
US Pat. No. 9,414,612

THRAUSTOCHYTRIDS, FATTY ACID COMPOSITIONS, AND METHODS OF MAKING AND USES THEREOF

DSM IP Assets B.V., TE H...

1. A food product, cosmetic, or pharmaceutical composition for animals or humans, comprising a microbial oil produced from
an isolated thraustochytrid species deposited under ATCC Accession No. PTA-9695, wherein the total fatty acids produced by
said microorganism comprise 10% or less by weight eicosapentaenoic acid.
US Pat. No. 9,406,826

FLEXIBLE ELECTRICAL GENERATORS

DSM IP ASSETS B.V., Heer...

1. A flexible electrical generator comprising:
a flexible support comprising woven high-strength polymeric fibers and a plastomer impregnating the woven high-strength polymeric
fibers, and at least one photovoltaic device attached to the flexible support, wherein

the plastomer is a semi-crystalline copolymer of ethylene or propylene and one or more C2 to C12 ?-olefin co-monomers, and
wherein the plastomer has a density as measured according to ISO1183 of between 860 and 930 kg/m3.

US Pat. No. 9,260,558

WATER DILUTABLE UV-CURABLE POLYURETHANE

DSM IP ASSETS B.V., Heer...

1. An aqueous composition comprising:
(a) 70 to 99 wt. % of a water dilutable UV-curable polyurethane having a weight average molecular weight of less than 30,000
gmol?1 and an acid value of less than 20 mg KOH/g; and

(b) 1 to 30 wt. % of an aqueous medium, wherein
components (a) and (b) add up to 100%, and wherein
the water dilutable UV-curable polyurethane contains ethylene oxide groups, the water dilutable UV-curable polyurethane being
obtained from components comprising at least:

(i) 1 to 25 wt. % of at least one polyisocyanate;
(ii) 0 to 80 wt. % of at least one hydroxyl functional compound containing ethylene oxide groups;
(iii) 10 to 90 wt. % of at least one hydroxyl functional compound containing at least one polymerisable unsaturated (meth)acryloyl
functional group per molecule; and

(iv) 0 to 50 wt. % of at least one isocyanate-reactive compound not comprised by (ii) or (iii); wherein
the sum of (i) to (iv) is 100%, and wherein
the water dilutable UV-curable polyurethane is free of organic solvent and when diluted with water forms a homogenous phase
with the water such that the polyurethane upon dilution with water has a viscosity which does not exceed a viscosity of the
polyurethane at 100% solids, and wherein

the sum of ethylene oxide groups originating from components (ii) and (iii) is at least 25 wt. % and less than 75 wt. % based
on the weight of the polyurethane.

US Pat. No. 9,181,573

METHOD FOR IMPROVING THE YIELD OF A POLYPEPTIDE

DSM IP ASSETS B.V., Heer...

1. A method for the production of a polypeptide of interest by a eukaryotic host cell, which method comprises modifying a
value of a set of relevant protein features in an amino acid backbone of the polypeptide to fall within an optimal range or
to become closer to an optimal value for one or more protein features in the eukaryotic host, wherein said protein features
are properties that can be calculated from the protein amino acid sequence and DNA sequence, the method comprising the steps
of:
(i) providing a sequence for the polypeptide of interest,
(ii) determining an optimal range and an optimal value for one or more protein features in the eukaryotic host,
(iii) determining a set of relevant protein features in the eukaryotic host, which features will improve secretion of the
polypeptide by the eukaryotic host if one or more of said relevant features is modified in the amino acid backbone of the
polypeptide of interest, and

(iv) modifying the sequence for the polypeptide of interest such that the value of the relevant protein features falls within
the optimal range or closer to the optimal value as determined in (i), and

(v) producing the modified polypeptide by the eukaryotic host cell,
wherein said method improves the secretion of said polypeptide of interest,
wherein the specificity and/or specific activity of the polypeptide after said modifying substantially remains the same as
before improvement of the secretion,

wherein (i) and (ii) may be performed in any order,
wherein the relevant set of protein features is determined by:
a. collecting or creating a dataset S, which contains secretion levels of a suitable amount of proteins in a certain eukaryotic
host and amino acid and DNA sequences thereof;

b. calculating values of protein features (F) for all proteins in the dataset S;
c. using a statistical classification method to select a subset of protein features (Fs) that gives the best performance of
a statistical classifier to distinguish between secreted proteins (S+) and non-secreted proteins (S?) in the dataset S, according
to a suitably defined classifier performance criterion; and

wherein the optimal range or the optimal value of protein features for a eukaryotic host is determined by:
d. collecting or creating a dataset S, which comprises secretion levels of a suitable amount of proteins in a certain eukaryotic
host and amino acid and DNA sequences thereof;

e. calculating protein features (F) for all proteins in the dataset S;
f. determining an optimal value (F opt) for each feature for the eukaryotic host by fitting a probability distribution for
each protein feature calculated from secreted proteins (S+) such that the distribution of the feature values is well described
by the chosen probability distribution;

g. determining an optimal range of each feature for the eukaryotic host;
wherein the relevant set of protein features is selected from the group consisting of: the number of amino acids, molecular
weight, isoelectric point, net charge at a specific pH, GRAVY score, aliphatic index, instability index, compositional features,
atomic composition of C, H, N, O, S atoms, amino acid frequency, dipeptide frequency, tripeptide frequency, acidic amino acid
frequency, aliphatic amino acid frequency, aromatic amino acid frequency, basic amino acid frequency, local features, localization
features, glycosylation pattern and/or charged amino acid frequency.

US Pat. No. 9,115,378

FERMENTATIVE VITAMIN C PRODUCTION

DSM IP ASSETS B.V., Heer...

1. A process for the fermentative production of Vitamin C, comprising: cultivating a host cell selected from the group consisting
of Gluconobacter, Gluconacetobacter and Acetobacter to allow the direct production of Vitamin C from a carbon source obtainable from D-glucose or D-sorbitol metabolization pathway,
wherein the genome of said host cell is genetically engineered with a polynucleotide encoding L-sorbosone dehydrogenase selected
from the group consisting of: (i) a polynucleotide comprising the nucleotide sequence of SEQ ID NO:1; (ii) a polynucleotide
encoding L-sorbosone dehydrogenase that has the ability to directly convert L-sorbosone into Vitamin C comprising the amino
acid sequence of SEQ ID NO:2; (iii) a polynucleotide that hybridizes under highly stringent conditions to a polynucleotide
encoding L-sorbosone dehydrogenase that has the ability to directly convert L-sorbosone into Vitamin C comprising the amino
acid sequence of SEQ ID NO:2, and wherein said highly stringent conditions comprise hybridization at 42° C. for 2 to 4 days
followed by two washes in 2×SSC, 0.1% SDS at room temperature and two washes in 0.5×SSC, 0.1% SDS or 0.1×SSC, 0.1% SDS at
65° C. to 68° C.; and (iv) a polynucleotide that is at least 95% identical to a polynucleotide encoding L-sorbosone dehydrogenase
that has the ability to directly convert L-sorbosone into Vitamin C comprising the amino acid sequence of SEQ ID NO:2, and
wherein a polynucleotide that encodes a Sorbitol/Sorbose Metabolization System (SMS) protein having the amino acid sequence
of SEQ ID NO:137 is overexpressed, and isolating Vitamin C from the cell or the culture medium.
US Pat. No. 9,114,929

PROCESS FOR FOIL RIPENING OF CHEESE

DSM IP ASSETS B.V., Heer...

1. A packaging for a food product having an opening for receiving the food product, wherein the packaging comprises a thermoplastic,
monolithic film and wherein the packaging has a water vapor transmission rate of at least 10 g/m2/24 hours at 10° C. and 85% relative humidity and an oxygen permeability of at most 100 cm3/m2/24 hours/atm at 10° C. and 85% relative humidity when closed, and wherein the packaging has dimensions corresponding to the
dimensions of the food product when closed.
US Pat. No. 9,074,038

STAIN RESISTANT URETHANE-VINYL AQUEOUS COATING COMPOSITIONS

DSM IP ASSETS B.V., Heer...

1. An aqueous coating composition comprising:
(i) 20 to 80 wt % of a polyurethane A obtained by the reaction of:
(a) an isocyanate-terminated prepolymer formed from components comprising:
(1) 20 to 80 wt % of at least one polyisocyanate;
(2) 3 to 10 wt % of at least one isocyanate-reactive polyol of weight average molecular weight <500 Daltons, containing at
least one ionic or potentially ionic water-dispersing group;

(3) 0 to 15 wt % of at least one isocyanate-reactive polyol containing non ionic water-dispersing groups;
(4) 17 to 77 wt % of at least one isocyanate-reactive polyol other than (3) having a weight average molecular weight within
a range of 500 to 8000 Daltons and a ring structure content >30 wt. %;

(5) 0 to 20 wt % of at least one isocyanate-reactive polyol other than (2) or (3) of weight average molecular weight 500 Daltons;
where (1), (2), (3), (4) and (5) add up to 100%;
wherein the polyols (a)(3) to (5) have a total ring structure content 48 wt %; and
(b) an active-hydrogen chain extending compound;
wherein polyurethane A has an acid value in the range of from 8 to 40 mg KOH/g and a hard segment content ?40 wt % by weight
of polyurethane A; and

(ii) 80 to 20 wt % of a vinyl polymer B with a glass transition temperature ?20° C., wherein vinyl polymer B comprises vinyl
monomers comprising in total ?70 wt % carbon, nitrogen and halogen based on vinyl monomer molecular weight; wherein

(i) and (ii) add up to 100%; and wherein
a film having a wet film thickness of 12 microns formed of the composition exhibits a moisture vapour transmission rate of
?500 g/m2/24 h.

US Pat. No. 9,809,565

FORMATION OF CHIRAL 4-CHROMANONES USING CHIRAL PYRROLIDINES IN THE PRESENCE OF UREAS OR THIOUREAS

DSM IP ASSETS B.V., Heer...

1. A process for the manufacturing of compound of formula (I)

comprising the step of reacting a compound of formula (II-A) and a compound of formula (II-B) in the presence of at least
one chiral compound of formula (II-C) and in the presence of at least one urea compound of formula (X-A) or at least one thiourea
compound of formula (X-B):


wherein:
R1, R3 and R4 are independently from each other hydrogen or methyl groups;

R2 and R2? represents hydrogen or a phenol protection group;

R5 represents either a linear or branched completely saturated C6-25-alkyl group or a linear or branched C6-25-alkyl group comprising at least one carbon-carbon double bond;

Y1 represents either CH2Y2 or

wherein
R6 represents a linear or branched C1-12-alkyl group which optionally further comprises at least one aromatic group and/or C?O and/or NH and/or NH2 group;

Y2 represents either OH or OR7 or NHR7 or NHCOOR7 or


 and wherein
R7 represents either

a linear or branched C1-12-alkyl group which optionally further comprises at least one aromatic group and/or C?O and/or NH and/or NH2 group

or
an aryl group or a substituted aryl group or a heteroaryl group or a substituted heteroaryl group, and wherein
the dotted line represents the a bond by which the corresponding substituent is bound to the rest of formula (II-C); and wherein
the symbol * represents the chiral centre of the chiral isomer of formula (I); and
wherein
(1) Z1 represents either H or a group CH2Z4;

Z2 represents either H or a group CH2Z4;

Z3 represents either H or a group CH2Z4; wherein

Z4 represents H or an C1-C6 alkyl group; or wherein

(2) Z1, Z2 or Z3 is a group of formula (XII):


 wherein
Z5 is a C1-C6 alkyl group or a CF3 group and n stands for 0, 1, 2 or 3, with the proviso that if Z1 is different from H, that Z2 represents H, and wherein the compound of formula (IIc) is selected from the group consisting of:


US Pat. No. 9,505,699

PROCESS OF PRODUCTION OF DEHYDROLINALYL ACETATE (I)

DSM IP ASSETS B.V., Heer...

1. A process for the production of dehydrolinalyl acetate (DLA) which is a compound of formula (I):

 wherein
the process comprises reacting dehydrolinalool (DLL) which is a compound of formula (II):

with acetic anhydride which is a compound of formula (III):

in the presence of at least one catalyst of formula (VIII):

 wherein
M is Zn and x is 2 or M is Sc and x is 3.
US Pat. No. 9,457,515

RADIATION CURABLE RESIN COMPOSITION AND RAPID THREE-DIMENSIONAL IMAGING PROCESS USING THE SAME

DSM IP Assets B.V., Heer...

1. A liquid radiation curable resin comprising:
(A) from about 0 to about 12 wt % of a cycloaliphatic epoxide having a linking ester group;
(B) from about 30 to about 65 wt % of one or more epoxy functional components, wherein element (B) is not the same as element
(A);

(C) from about 10 to about 30 wt % of one or more oxetanes;
(D) from about 1 to about 10 wt % of one or more polyols;
(E) from about 2 to about 20 wt % of one or more radically curable (meth) acrylate components;
(F) from about 2 to about 12 wt % of one or more impact modifiers;
(G) from about 0.1 to about 8 wt % of one or more free radical photoinitiators; and
(H) from about 0.1 to about 8 wt % of one or more cationic photoinitiators;
wherein the one or more epoxy functional components other than (A) comprises a mono-functional epoxy with an ethylhexyl chain.
US Pat. No. 9,457,108

PASTEURISATION PROCESS FOR MICROBIAL CELLS AND MICROBIAL OIL

DSM IP Assets B.V., TE H...

1. A microbial oil comprising docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and mixtures thereof having a triglyceride
content of at least 90%; a peroxide value (POV) of less than 1.5, or optionally less than 1.0; and/or an anisidine value (AnV)
of less than 15, or optionally less than 12.
US Pat. No. 9,452,961

(6R,10R)-6,10,14-TRIMETYLPENTADECAN-2-ONE PREPARED FROM 6,10-DIMETYLUNDEC-5-EN-2-ONE OR 6,10-DIMETYLUNDECA-5,9-DIEN-2-ONE

DSM IP ASSETS B.V., Heer...

1. A process of manufacturing (6R,10R)-6,10,14-trimethylpentadecan-2-one in a multistep synthesis from 6,10-dimethylundec-5-en-2-one
or 6,10-dimethylundeca-5,9-dien-2-one comprising the sequential steps of:
a) providing a mixture of (E)-6,10-dimethylundec-5-en-2-one and (Z)-6,10-dimethylundec-5-en-2-one or a mixture of (E)-6,10-dimethylundeca-5,9-dien-2-one
and (Z)-6,10-dimethylundeca-5,9-dien-2-one;

b) separating one isomer of 6,10-dimethylundec-5-en-2-one or of 6,10-dimethylundeca-5,9-dien-2-one from the mixture of step
a);

c) conducting asymmetric hydrogenation using molecular hydrogen in the presence of a chiral iridium complex and yielding (R)-6,10-dimethylundecan-2-one;
d) chemically transforming (R)-6,10-dimethylundecan-2-one to a mixture of (R,E)-6,10,14-trimethylpentadec-5-en-2-one and (R,Z)-6,10,14-trimethylpentadec-5-en-2-one;
e) separating one isomer of (R)-6,10,14-trimethylpentadec-5-en-2-one from the mixture obtained in step d); and
f) conducting asymmetric hydrogenation using molecular hydrogen in the presence of a chiral iridium complex and yielding (6R,10R)-6,10,14-trimethylpentadecan-2-one,
wherein

step d) is practiced by:
d1) ethynylation of (R)-6,10-dimethylundecan-2-one using ethyne in the presence of a basic substance to yield (7R)-3,7,11-trimethyldodec-1-yn-3-ol;
and

d2) hydrogenation of (7R)-3,7,11-trimethyldodec-1-yn-3-ol with molecular hydrogen in the presence of a Lindlar catalyst to
yield (7R)-3,7,11-trimethyldodec-1-en-3-ol;

or step d) is practiced by:
d1?) vinylation of (R)-6,10-dimethylundecan-2-one by addition of a vinyl Grignard reagent to yield (7R)-3,7,11-trimethyldodec-1-en-3-ol;
followed by either
d3) reacting (7R)-3,7,11-trimethyldodec-1-en-3-ol with 2-methoxyprop-1-ene to yield a mixture of (R,E)-6,10,14-trimethylpentadec-5-en-2-one
and (R,Z)-6,10,14-trimethylpentadec-5-en-2-one;

or
d3?) reacting (7R)-3,7,11-trimethyldodec-1-en-3-ol with an alkyl acetoacetate or diketene in the presence of a base and/or
an acid to yield a mixture of (R,E)-6,10,14-trimethylpentadec-5-en-2-one and (R,Z)-6,10,14-trimethylpentadec-5-en-2-one.

US Pat. No. 9,447,017

PROCESS FOR THE PRODUCTION OF 4-ALKANOYLOXY-2-METHYLBUTANOIC ACID

DSM IP ASSETS B.V., Heer...

1. A process for producing a compound of formula (I):

wherein R signifies a C1-C15 alkyl moiety or a C2-C18 alkenyl moiety,

wherein the process comprises oxidizing a compound of formula (II):

wherein R in formula (II) is the same as defined for the compound of formula (I), in an oxygen-containing gas and in the presence
of at least one transition metal salt as a catalyst.

US Pat. No. 9,434,676

FLAVOR AND FRAGRANCE FORMULATION (VI)

DSM IP ASSETS B.V., Heer...

1. A flavor and fragrance formulation comprising at least one compound of formula (I):

wherein R1 is —OH or —O(CO)CH3.

US Pat. No. 9,434,814

UNSATURATED POLYESTER RESIN COMPOSITIONS

DSM IP ASSETS B.V., Heer...

1. A two-component composition comprising a first component and a second component, wherein
the first component is a pre-accelerated resin composition having an acid value in the range of from 0.001-300 mg KOH/g of
resin composition, the resin composition comprising (i) an unsaturated polyester resin having a molecular weight in a range
of 500 to 200,000 g/mole, (ii) an accelerator consisting essentially of a copper2+ compound in an amount of least 50 ppm, based on the primary resin system, and (iii) at least one N-containing organic base
selected from an amine compound and/or an ammonium salt; wherein the amine compound has the following formula:


and the ammonium salt has the following formula:
R1R2R3N+H

whereby R1, R2 and R3 each individually may represent hydrogen (H), C1-C20 alkyl, C5-C20 cycloalkyl or C7-C20 alkylaryl, that each optionally may contain one or more hetero-atoms and/or substituents and a ring may be present between
R1 and R2, R2 and R3 and/or R1 and R3, which may contain heteroatoms, wherein

the second component comprises a peroxide compound, and wherein
the two-component composition contains less than 0.01 mmol cobalt per kg primary resin system, and wherein
a molar ratio between the copper and basic functionality of the base is from 40:1 to 1:125.

US Pat. No. 9,404,558

HEAVY-DUTY CHAIN

DSM IP ASSETS B.V., Heer...

1. A heavy-duty chain containing chain-links comprising synthetic polymeric yarns, wherein when said chain is kept at least
taut onto an essentially planar surface, each chain-link has an orthographic projection onto said planar surface, said projection
having a foot print area (A), wherein the foot print areas denoted as A1 and A2 of every two adjacent links are in a relation:
80% A2?A1?100% A2 with A1 being the smallest of said two areas and wherein the projection is done in such a way that the ratio of the foot print areas
A2 to A1 is maximized.
US Pat. No. 9,376,535

BRANCHED POLYAMIDE WITH DIFFERENT BLOCKS

DSM IP ASSETS B.V., Heer...

1. A process for the preparation of a high molecular weight branched polyamide comprising the steps of:
(1) a melt-mixing step which comprises providing (i) a linear polyamide (pre)polymer (X-1) consisting essentially of AA-BB
repeat units, (ii) a linear polyamide (pre)polymer (X-2) consisting essentially of AB repeat units, and (iii) a branching
agent, to a melt mixing apparatus and mixing and heating components (i)-(iii) in the melt-mixing apparatus thereby forming
a mixed melt, and thereafter cooling the mixed melt to thereby form a solid mixture; and

(2) a solid state post condensation step which comprises subjecting the solid mixture to post-condensation at elevated temperature
in the solid state, thereby forming a high molecular weight branched polyamide, wherein

the (pre)polymers (X-1) and (X-2) are provided in a weight ratio (X-1)/(X-2) in a range of 0.25-4;
the (pre)polymer (X-1) and/or the (pre)polymer (X-2) have a viscosity number (VN), measured according to ISO 307, in a range
of 50-250 mL/g;

the branching agent is a branched polyamide oligomer/prepolymer (Y) comprising (a) a branching unit formed from a monomer
C having at least three functional groups, wherein the at least three functional groups may be the same or different and are
selected from the group consisting of amino groups, carboxylic acid functional groups and alkyl ester or acid chloride derivatives
thereof, and (b) AA-BB repeat units and/or AB repeat units;

the branching unit is present in an amount in a range of 0.05-1 mole %, relative to the total molar amount of AA repeat units,
BB repeat units and AB repeat units of the (pre)polymers (X-1) and (X-2) and the branched polyamide oligomer/prepolymer (Y);

the high molecular weight branched polyamide obtained after the solid state post condensation step has a relative viscosity
(RV) measured according to ISO 307 of at least 2.5, and

the AA repeat units represent units derived from a diamine monomer A, the BB repeat units represent units derived from a dicarboxylic
monomer B and the AB repeat units represent units derived from an ?,?-amino acid or a cyclic lactam derivative thereof.

US Pat. No. 9,301,533

ALPHA-AMYLASE VARIANTS

DSM IP ASSETS B.V., Herl...

1. A variant polypeptide having alpha-amylase activity, wherein the variant has an amino acid sequence which, when aligned
with an alpha-amylase comprising the sequence set out in SEQ ID NO: 2, comprises at least one substitution of an amino acid
residue corresponding to any of amino acid positions
13, 70, 75, 129, 133, 254, 281, 282, and 358, said positions being defined with reference to SEQ ID NO: 2, wherein the variant
is at least 90% identical to SEQ ID NO: 2, and wherein the variant has at least one altered property as compared with a reference
polypeptide having alpha-amylase activity, wherein the at least one altered property is increased sucrose tolerance.

US Pat. No. 9,181,429

ANTI-YELLOWING POLYAMIDE COMPOSITION

DSM IP ASSETS B.V., Heer...

1. A polymer composition comprising:
(a.) 90 to 40 wt % of at least one semi-aromatic polyamide;
(b.) 10 to 60 wt % of at least one aliphatic polyamide;
(c.1) at least one white pigment; and
(c.2) optionally at least one secondary component, wherein
the sum of the amount of the at least one semi-aromatic polyamide and the at least one aliphatic polyamide is 100 wt % and
the at least one white pigment is present in an amount of at least 10 wt. %, calculated based on the total weight of the composition,
and wherein:

(i.) the semi-aromatic polyamide is derived from one or more aliphatic diamine monomers containing 4 to 12 carbon atoms and
one or more benzene dicarboxylic acid monomers;

(ii.) the aliphatic polyamide is derived from one or more aliphatic diamine monomers containing 4 to 10 carbon atoms and one
or more aliphatic dicarboxylic acids with 6 to 12 carbon atoms; and

(iii.) the diamine in the at least one semi-aromatic polyamide comprises diamino butane.
US Pat. No. 9,182,397

IMMUNOASSAY FOR DETECTING ANTIBIOTICS

DSM IP ASSETS B.V., Heer...

1. A method for detecting a beta-lactam antibiotic in a sample, said method comprising:
a) contacting a liquid sample with a labeled antibiotic binding protein obtained from an antibiotic-sensitive Bacillus stearothermophilus and a labeled control reagent, wherein the labeled antibiotic binding protein and the labeled control reagent are present
in a container, to form a liquid composition in the container,

b) providing a test device having a proximal and a distal end, said test device configured to allow lateral flow from the
proximal to the distal end, said test device comprising a solid support comprising the following regions in sequence from
the proximal to the distal end:

i. a sample receiving region,
ii. a detection region, said detection region comprising at least two zones:
A. a detection zone comprising an immobilized antibiotic capable of binding the labeled antibiotic binding protein, when said
labeled antibiotic binding protein is unbound by antibiotic from the sample, and

B. a control zone comprising an immobilized binding agent capable of binding the labeled control reagent,
iii. an absorbing region, and
iv. optionally, a handling region,
c) contacting the liquid composition of part a) with the sample receiving region of the test device of part b),
d) allowing the liquid composition to move from the sample receiving region through the detection region to the absorbing
region, so as to allow the liquid composition comprising the labeled antibiotic binding protein and the labeled control reagent
to contact the detection zone and the control zone,

e) detecting a signal at the detection zone and a signal at the control zone, wherein
i. an absence of antibiotic in the sample is indicated by a presence of a signal at the detection zone that is more intense
than the signal at the control zone, and

ii. a presence of antibiotic in the sample is indicated by an absence of a signal at the detection zone or a presence of a
signal at the detection zone that is less intense than the signal at the control zone.

US Pat. No. 9,175,050

POLYPEPTIDE HAVING SWOLLENIN ACTIVITY AND USES THEREOF

DSM IP ASSETS B.V., Heer...

1. A variant polypeptide having at least 95% sequence identity with the sequence set out in SEQ ID NO: 2 or the mature form
thereof, wherein said variant polypeptide or mature form thereof has one or more substitutions or insertions relative to SEQ
ID NO:2 and wherein said variant polypeptide has swollenin activity.
US Pat. No. 9,120,895

FLEXIBLE POLYMER

DSM IP ASSETS B.V., Heer...

1. A thermoplastic elastomer comprising hard segments of polyester and soft segments, wherein the soft segments consist of
a pre-polymerized condensation reaction product residue mixture consisting of dimerised fatty acids and dimerised fatty amines.
US Pat. No. 9,121,115

YARN, A PROCESS FOR MAKING THE YARN, AND PRODUCTS CONTAINING THE YARN

DSM IP ASSETS B.V., Heer...

1. A cut resistant yarn comprising a blend, wherein the blend consists of first and second staple fibers, wherein:
a) the first staple fibers are polymer-fibers, each first staple fiber comprising a polymer body encasing a hard component,
said hard component being a plurality of hard fibers, said hard fibers having an average diameter of at most 25 microns; and

b) the second staple fibers are different than the first staple fibers, and wherein
the first to second staple fibers are present in the blend in a weight ratio from 1:99 to 99:1.
US Pat. No. 9,808,018

ALPHA-AMYLASE VARIANTS

DSM IP ASSETS B.V., Heer...

1. A variant polypeptide having alpha-amylase activity, wherein the variant has an amino acid sequence which, when aligned
with the alpha-amylase comprising the sequence set out in SEQ ID NO: 2, comprises at least one substitution of an amino acid
residue corresponding to any of amino acids
16, 45, 72, 77, 94, 134, 174, 177, 178, 186, 210, 234, 283, 284, 323, 325, 652,
said positions being defined with reference to SEQ ID NO: 2 wherein the alpha-amylase polypeptide variant is at least 90%
identical to SEQ ID NO: 2, and wherein the variant has one or more altered properties as compared with a reference polypeptide
having alpha-amylase activity, wherein the at least one altered property is an increased sucrose tolerance.

US Pat. No. 9,458,076

USING MIXTURES OF E/Z ISOMERS TO OBTAIN QUANTITATIVELY SPECIFIC PRODUCTS BY COMBINED ASYMMETRIC HYDROGENATIONS

DSM IP ASSETS B.V., Heer...

1. A process of manufacturing a compound of formula (I-A) or (I-B) or an acetal or a ketal thereof from a mixture of E/Z isomers
of compound of formula (I) or (II) or an acetal or a ketal thereof:

wherein Q stands for H or CH3 and m and p stand independently from each other for a value of 0 to 3 with the proviso that the sum of m and p is 0 to 3,
and

wherein a wavy line represents a carbon-carbon bond which is linked to the adjacent carbon-carbon double bond so as to have
said carbon-carbon double bond either in the Z or in the E-configuration and where the substructures in formula (I) and (II)
represented by s1 and s2 can be in any sequence; and

wherein the double bond having dotted lines () in formula (I) or (II) represent either a single carbon-carbon bond or a double carbon-carbon bond; wherein
the process comprises the steps of:
a) separating by distillation the isomers having E-configuration from the isomers having Z-isomers in the mixture of isomers
of compound of formula (I) or (II) or the acetal or ketal thereof;

b) submitting the isomers having the E-configuration of compound of formula (I) or (II) or the acetal or ketal thereof to
hydrogenation by molecular hydrogen in the presence of a chiral iridium complex of formula (III) having the S-configuration
at the stereogenic centre indicated by *;

c) submitting the isomers having the Z-configuration of compound of formula (I) or (II) or the acetal or ketal thereof to
hydrogenation by molecular hydrogen in the presence of a chiral iridium complex of formula (III) having the R-configuration
at the stereogenic centre indicated by the symbol *; and

d) optionally combining the hydrogenated products of step b) and c);
wherein
n is 1, 2 or 3;
X1 and X2 are independently from each other selected from the group consisting of hydrogen atoms, C1-4-alkyl, C5-7-cycloalkyl, adamantyl, phenyl optionally substituted with one to three C1-5-alkyl, C1-4-alkoxy, C1-4-perfluoroalkyl groups and/or one to five halogen atoms, benzyl, 1-naphthyl, 2-naphthyl, 2-furyl and ferrocenyl;

Z1 and Z2 are independently from each other selected from the group consisting of hydrogen atoms, C1-5-alkyl and C1-5-alkoxy groups or Z1 and Z2 stand together for a bridging group forming a 5 to 6 membered ring;

Y? is an anion selected from the group consisting of halide, PF6?, SbF6?, tetra(3,5-bis(trifluoromethyl)phenyl)borate(BArF?), BF4?, perfluorinated sulfonates, ClO4?, Al(OC6F5)4?, Al(OC(CF3)3)4?, N(SO2CF3)2?N(SO2C4F9)2? and B(C6F5)4?;

R1 represents either phenyl, o-tolyl, m-tolyl or p-tolyl or a group of formula (IVa) or (IVb) or (IVc):


wherein R2 and R3 represent either both H or a C1-C4-alkyl group or a halogenated C1-C4-alkyl group or represent a divalent group forming together a 6-membered cycloaliphatic or an aromatic ring which optionally
is substituted by halogen atoms or by C1-C4-alkyl groups or by C1-C4-alkoxy groups;

R4 and R5 represent either both H or a C1-C4-alkyl group or a halogenated C1-C4-alkyl group or a divalent group forming together a 6-membered cycloaliphatic or an aromatic ring which optionally is substituted
by halogen atoms or by C1-C4-alkyl groups or by C1-C4-alkoxy groups;

R6 and R7 and R8 represent each a C1-C4-alkyl group or a halogenated C1-C4-alkyl group;

R9 and R19 represent either both H or a C1-C4-alkyl group or a halogenated C1-C4-alkyl group or a divalent group forming together a 6-membered cycloaliphatic or an aromatic ring which optionally is substituted
by halogen atoms or by C1-C4-alkyl groups or by C1-C4-alkoxy groups; and wherein

the symbol * represents a stereogenic centre of the complex of formula (III).
US Pat. No. 9,441,214

POLYPEPTIDE HAVING BETA-GLUCOSIDASE ACTIVITY AND USES THEREOF

DSM IP ASSETS B.V., Heer...

1. A variant polypeptide having at least 98% sequence identity with the sequence set out in SEQ ID NO: 2 or the mature form
thereof, wherein said variant polypeptide or mature form thereof has one or more substitutions or insertions relative to SEQ
ID NO:2 and wherein said variant polypeptide has beta-glucosidase activity.
US Pat. No. 9,309,406

FUEL PART AND PROCESS FOR PRODUCING OF A FUEL PART

DSM IP ASSETS B.V., Heer...

1. A fuel part for contact with a hydrocarbon fuel, wherein the fuel part is formed of a polymer composition comprising:
(i.) at least 80 wt. % based on total weight of the polymer composition of at least one aliphatic polyamide selected from
the group consisting of polyamide-6 (PA6), polyamide-66 (PA66), polyamide-410 (PA410) and polyamide-46 (PA46) having a ratio
of terminal carboxy group concentration over terminal amino group concentration which is equal to 1 or higher,

(ii.) 0.001 wt. % to 0.8 wt. % based on total weight of the polymer composition of a micro talcum having a median diameter
of less than 1 micrometer; and

(iii.) 5 wt. % to 50 wt. % based on total weight of the polymer composition of an impact modifier, wherein
the fuel part is selected from the group consisting of fuel containers, fuel canisters, fuel caps and fuel hoses, and wherein
the fuel part exhibits a fuel permeation rate for the hydrocarbon fuel measured by a weight loss method according to ASTM
E96BW using ASTM fuel CE10 which is less than a comparable fuel part formed of an identical polymer composition not containing
the micro talcum.

US Pat. No. 9,255,176

SURFACE MODIFICATION OF POLYMERS VIA SURFACE ACTIVE AND REACTIVE END GROUPS

DSM IP ASSETS B.V., Heer...

1. A method of modifying a surface on a polymeric substrate selected from the group consisting of solid synthetic polymers,
solid natural polymers, and hydrogels, comprising the steps of:
fabricating an article from a polymeric body composed of polymeric molecules having first reactive endgroups tethered to surface
active spacers as part of polymer chain ends, which surface active spacers comprise endgroups on said polymeric molecules
and forming a surface of said first reactive endgroups linked to surface active spacers on said polymeric body, said polymeric
body bearing said first reactive endgroup being an isocyanate-terminated polyurethane;

contacting the surface of said polymeric body with a compound containing at least one third reactive endgroup and at least
one fourth reactive endgroup to react said at least one third reactive endgroup with a first reactive endgroup and thereby
link said at least one fourth reactive endgroup to the polymeric molecules by a covalent or ionic bond; and

contacting the resulting surface of said polymeric body with a compound containing at least one second reactive group and
at least one surface modifying moiety, selected from the group consisting of sugars, peptides, and proteins, to react said
at least one second reactive endgroup with said at least one fourth reactive endgroup and thereby link said at least one surface
modifying moiety to one of said polymeric molecules by a covalent, coordination, or ionic bond,

wherein said first and third reactive endgroups and said second and fourth reactive endgroups are respectively selected to
be a pair of reactive groups selected from the group consisting of a hydroxyl group and an isocyanate group and a alkyne group
and an azido group, and

wherein said first reactive endgroups are spontaneously brought to the surface of said article during the fabrication thereof
by a fabrication method that comprises thermal forming or solvent-based processing,

the polymeric substrate with a modified surface having the formula
wherein R is a sugar, peptide, or protein moiety and Polymer is a polyurethane.

US Pat. No. 9,181,401

PHOSPHORYLCHOLINE-BASED AMPHIPHILIC SILICONES FOR MEDICAL APPLICATIONS

DSM IP ASSETS B.V., Heer...

1. A polymerizable silicone compound comprising a silicone moiety having a weight average molecular weight of from 500 to
50,000 Daltons, wherein said polymerizable silicone compound is selected from the group consisting of
compounds having the formula (I)

wherein:
R1 is an alkyl or alkoxy group of linear, branched, or cyclic structure, or an aromatic group, having up to 20 carbon atoms;

R2 and R3 are the same or different groups selected from alkyl, trialkylsiloxy, silicone, alkoxy, alicyclic, and aromatic groups;

n is a number of repeat silicone units from 1 to 700 units;
R4 is an alkylene, polyether, perfluorinated polyether, carbamate, ester, amide, or urea linkage having up to 30 linking atoms;

R5 and R6 are the same or different alkyl, alkoxy, or aromatic groups or alicyclic rings containing 3 to 6 carbon atoms;

R7 is H or an alkyl group containing 1 to 6 carbon atoms; and

X is O, NH, or N—C1-6alkyl,

compounds having the formula (II)

wherein:
R2 and R3 are the same or different groups selected from alkyl, trialkylsiloxy, silicone, alkoxy, alicyclic, and aromatic groups;

n is a number of repeat silicone units from 1 to 700 units;
R4 is an alkylene, polyether, perfluorinated polyether, carbamate, ester, amide, or urea linkage having up to 30 linking atoms;

R5 and R6 are the same or different alkyl, alkoxy, or aromatic groups or alicyclic rings containing 3 to 6 carbon atoms;

R7 is H or an alkyl group containing 1 to 6 carbon atoms; and

X is O, NH, or N—C1-6alkyl,

compounds having the formula (III)

wherein:
R1 is an alkylene or polyether linking group of linear or branched low molecular weight or oligomeric structure having up to
10 carbon atoms;

R2 and R3 are the same or different groups selected from alkyl, trialkylsiloxy, silicone, alkoxy, alicyclic, and aromatic groups;

n is a number of repeat silicone units from 1 to 700 units;
R4 is an alkylene, polyether, perfluorinated polyether, carbamate, ester, amide, or urea linkage having up to 30 linking atoms;

R5 and R6 are the same or different alkyl, alkoxy, or aromatic groups or alicyclic rings containing 3 to 6 carbon atoms;

R7 is H or an alkyl group containing 1 to 6 carbon atoms;

R8 is an alkyl or alkoxy group containing 1 to 22 carbon atoms; and

X is O, NH, or N—C1-6alkyl, and

compounds having the formula (IV)

wherein:
R1 is an alkylene or polyether linking group of linear or branched low molecular weight or oligomeric structure having up to
10 carbon atoms;

R2 and R3 are the same or different groups selected from alkyl, trialkylsiloxy, silicone, alkoxy, alicyclic, and aromatic groups;

n is a number of repeat silicone units from 1 to 700 units;
R4 is an alkylene, polyether, perfluorinated polyether, carbamate, ester, amide, or urea linkage having up to 30 linking atoms;

R5 and R6 are the same or different alkyl, alkoxy, or aromatic groups or alicyclic rings containing 3 to 6 carbon atoms;

R7 is H or an alkyl group containing 1 to 6 carbon atoms;

R8 is an alkyl or alkoxy group containing 1 to 22 carbon atoms; and

X is O, NH, or N—C1-6alkyl.

US Pat. No. 9,115,379

PROCESS FOR THE PRODUCTION OF A COMPOSITION CONTAINING 5?-RIBONUCLEOTIDES

DSM IP ASSETS B.V., Heer...

1. A process for producing a composition comprising 5?-ribonucleotides, said process comprising:
a) subjecting a microorganism to autolysis under conditions at which at least 50% of the RNA remains in a form degradable
into 5?-ribonucleotides;

b) subjecting the autolysate from a) to solid/liquid separation and recovering an RNA-containing cell wall fraction; and
c) converting RNA in the recovered RNA-containing cell wall fraction into 5?-ribonucleotides,
wherein the solid/liquid separation in b) is done at a pH of lower than 4.0 and higher than 1.0, and wherein at least 75%
of the RNA remains associated with the RNA-containing cell wall fraction obtained in b).

US Pat. No. 9,944,905

FUMARATE REDUCTASES

DSM IP ASSETS B.V., Heer...

1. A variant polypeptide having fumarate reductase activity, wherein the variant polypeptide has modified NADP(H)-dependent activity and/or modified NAD(H)-dependent activity as compared with a reference polypeptide having fumarate reductase activity and comprising the amino acid sequence of SEQ ID NO: 33,wherein the variant polypeptide comprises an amino acid sequence which, when aligned with the fumarate reductase comprising the amino acid sequence of SEQ ID NO: 33, comprises at least one substitution of an amino acid residue corresponding to any of amino acids
1042, 1071, 1072, 1082 or 1083
said positions being defined with reference to SEQ ID NO: 33,
wherein the variant polypeptide is a non-naturally occurring polypeptide, and
wherein the variant polypeptide is at least 85% identical to SEQ ID NO: 33.
US Pat. No. 9,808,022

PROCESS FOR MANUFACTURING OF A FERMENTED DAIRY PRODUCT

DSM IP ASSETS B.V., Heer...

1. A process for manufacturing a fermented dairy product comprising:
a. subjecting a milk base to fermentation with a starter comprising at least one Streptococcus salivarius thermophilus strain and at least one Lactobacillus delbrueckii subsp bulgaricus strain, until a desired pH value in a range of 4.0 and 5.0 is reached immediately at the end of fermentation;

b. optionally cooling a fermented milk base obtained in (a); and
c. packaging the fermented dairy product,wherein at least one Streptococcus salivarius thermophilus strain is weakly post-acidifying,wherein at least one Streptococcus salivarius thermophilus strain is selected from the group consisting of CBS129457 and CBS129458 andwherein the pH value of the packaged fermented dairy product is not less than 4.1 and does not fluctuate more than 0.3 pH
unit upon storage at 20° C. or 30° C. for 33 days after the end of fermentation, andwherein weakly post-acidifying is defined as having a two-phase acidification profile,wherein the two-phase acidification profile is determined by continuous recordation of pH as a function of time comprising
an initial period from inoculation to end of fermentation followed by a period where pH does not fluctuate more than 0.3 pH
unit in a Dutch milk composition comprising 1.5% (w/w) fat, 3.6% (w/w) protein, 4.6% (w/w) carbohydrates and 2% RSM powder
to make Dutch fermented milk product.